University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Doctoral Dissertations

Dissertations and Theses

October 2021

Understanding how CaMKII holoenzyme dynamics facilities
activation-triggered subunit exchange
Ana P. Torres-Ocampo
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2
Part of the Biochemistry Commons, Biophysics Commons, and the Molecular Biology Commons

Recommended Citation
Torres-Ocampo, Ana P., "Understanding how CaMKII holoenzyme dynamics facilities activation-triggered
subunit exchange" (2021). Doctoral Dissertations. 2371.
https://doi.org/10.7275/24533941 https://scholarworks.umass.edu/dissertations_2/2371

This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Understanding how CaMKII holoenzyme dynamics facilitates activation-triggered
subunit exchange

A Dissertation Presented
by
ANA PAMELA TORRES-OCAMPO

Submitted to the Graduate School of the

University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of

DOCTOR OF PHILOSOPHY

September 2021

Molecular and Cellular Biology

© Copyright by Ana Pamela Torres-Ocampo 2021
All Rights Reserved

Understanding how CaMKII holoenzyme dynamics facilitates activation-triggered
subunit exchange

A Dissertation Presented
by

ANA PAMELA TORRES-OCAMPO

Approved as to style and content by:

____________________________________________________

Margaret Stratton, Chair

____________________________________________________

Peter Chien, Member

____________________________________________________

Scott Garman, Member

____________________________________________________

Luke Chao, Member

____________________________________________________

Thomas Maresca

Molecular and Cellular Biology

DEDICATION

To my parents Maria Eugenia Ocampo-Vera and Jesus Fernando Torres-Mancilla, who
supported me through this whole process without ever doubting my capabilities as a

scientist, even when I questioned them. Thank you for being an endless source of support,
for loving me, and for making me who I am today.

And to my grandparents, Maria del Refugio Vera-Romo and Guillermo Ocampo-Gastaldi,

who are not here with me right now, but I know they are watching and celebrating my
triumphs.

“He said he had contemplated, from above, human life.

And said that we are a sea of little fires, tiny flames
The world is that—he revealed—
A cluster of people, a sea of little fires.
Each person shines with their own light among all others.
No two fires are alike.
There are large fires and small fires
and fires of all kinds and colors.
There are people of serene fire, unaware of the existence of wind,
and people of crazy fire, who fill the air with sparks.
Some fires, foolish fires, do not shine or burn;
but others burn life so heartily you cannot observe them without stopping to blink,
and whoever gets close, flares up”
Eduardo Galeano
The book of hugs

ACKNOWLEDGMENTS
I want to thank my mentor, Meg Stratton. I am incredibly grateful and consider

myself very lucky and thankful I have crossed paths with you. Your love and engagement

with science kept me going even though I was sure I did not have it in me. As I helped you
establish the fabulous Stratton lab and you took my hand and guided me on being a

scientist, we both relied on each other and made a great team. Something I will keep as an

example of a great mentor and scientist. I aspire to be like you when I grow up. Thank you.

I want to extend a warm thank you to my committee members: Dr. Scott Garman, Dr. Peter
Chien, and Dr. Luke Chao. Scott, I was lucky enough to be part of the joint xtal meeting

where I learned from you how to be a better scientist in all the ways possible. From creating
a PowerPoint presentation worthy of admiration would allow me to concisely communicate
my science, focusing on exciting questions and how to answer them. I had the privilege to

work with you as student body president for MCB. Thus, I was able to witness firsthand the
characteristics of a great leader. Thank you for that.

Peter, I remember being a first-year graduate student, half asleep and trying to

figure what I was doing, freezing up here in this little town in Western Mass. And you were

coming in to teach the Advanced Molecular biology course at 10 am. Anybody could see that
you loved being a scientist within 5 minutes of hearing you teach. By the end of the class, I

knew that it was precisely because of scientists like you that I was here and made the right
choice by pursuing my dream to be a scientist. Thank you.

Luke, in my mind, you were always this epic and worthy of legends scientist who

published the structure of CaMKII. After working with CaMKII for a few years, I know

v

how complicated she can be to study. Your feedback on my project and your wise

words about how hard it can be to do a Ph.D. but appreciating the people and relationships
along the way helped me a lot during these crazy times. Thank you.

To my labmates, Noelle, Roman, Can, Nidhi and Bao. All of us have made a great

team and look out for each other. You have been a part of a family away from home. I am

grateful to have been able to share my training as a scientist with you. I want to especially

thank Can Özden, who joined the lab in my third year. After that, very quickly, you became
like a brother to me. You are an annoying brother that inspired me with his pure love of

science. Apart from challenging me to be a better scientist, you were a constant source of
guaranteed laughter even in the not-so-great days of trying to complete a Ph.D. Words
cannot describe how grateful I am for your friendship; you are my rock!

I would also like to thank my superstar undergraduates Annie Gardella, Alfred

Samkutty, master’s student Christina Hacker and Daniel Flaherty. Annie and Alfred, your
energy and excitement for science were contagious, and you pushed me to be a better

scientist. We laughed, we cried together, and most importantly, we learned together. Thank
you for allowing me to be your mentor and enjoy doing science together. I am sure you are
up to great things, and I know your brilliant minds will let you get to do amazing things!

Christina, thank you for jumping into the projects so quickly and swiftly. I aspire to be as

organized as you one day. Even though you were my student for only one semester, your

hard work helped me finish my thesis, and I am forever grateful. Dan, you came in the ‘later’
years, but your hard work is worthy of admiration. Thank you for your dedication and
patience. We also learned together, and I am happy to have you on the team.

My family, dad, mom, and sister, thank you so much for putting up with my dreams

and me. Having big dreams meant that I was away from home for a while, and I missed
vi

many important things, but I could always go back home and feel your warmth and love.
Thank you for being my family and supporting me through everything.

Thank you to my roommates Ning-Hsuang Tseng, Guilherme Pagoti and Carina

Dreyer. Ning, we met a few days after starting our degree, and pretty quickly, I realized you

were stuck being my friend. We have been through the ups and downs of completing a Ph.D.
Your friendship has always been there, and I would not have achieved this degree without
you. Thank you for the laughter and all those good memories that included just talking

about life and drinking. Those are the moments that made this all worth it. Gui, I don’t think
I will ever meet somebody else who loves spiders as much as you do; keep studying them
with that rigorous passion. We ended up being roommates by a lucky chance, and you

quickly became family away from home. Thank you for your warmness and care. But most
importantly, thank you for introducing me to Pão de queijo. And Carina, your contagious

energy fueled the last months of this journey. Thank you for your support and your endless
amazingly tasting dishes that lifted my spirits!

Finally, thank you to Mariel Coradin. We met before we started a Ph.D. We met

before we even knew that we wanted to be scientists, and boy has it been a journey. Thank
you for your support and patience. Thank you for always saying yes to my crazy ideas and

for discussing science with me. Your friendship means the world to me, and I aspire to be as

good of a scientist as you.

Thank you to the MCB family, who was always there. A heartfelt thank you. 

vii

ABSTRACT

Understanding how CaMKII holoenzyme dynamics facilitates activation-triggered
subunit exchange
SEPTEMBER 2021

ANA PAMELA TORRES-OCAMPO, B.SC., UNIVERSITY OF PUERTO RICO-RÍO PIEDRAS
CAMPUS
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Margaret M. Stratton

Long-term memory and learning are still poorly understood from a molecular and cellular

standpoint. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is an oligomeric kinase

that is involved in this remarkable process. However, the molecular details of its specific
roles in these processes remains elusive. CaMKII activation-triggered subunit exchange

presents a novel possible mechanism involved in long-term memory and learning by

exchanging active subunits with other CaMKIIs. CaMKII subunit exchange also shows that

exchanged CaMKIIs spread their phosphorylation state to newly synthesized CaMKIIs. This
provides a long-lasting signal that might possibly be involved in long-term memory by

escaping a cell’s protein turnover. In this thesis work, I expanded understanding of CaMKII
activation-triggered subunit exchange to the other CaMKII human genes, CaMKIIγ and

CaMKIIδ. I also characterized CaMKIIα holoenzyme stability. I also uncovered a potential

new role for CaMKII oligomerization and how it is related to activation properties. Lastly, I
used CaMKII FRET biosensor Camui for a proof of concept using microscopy technology
FLIM-FRET.

viii

TABLE OF CONTENTS

Page
ACKNOWLEDGMENTS ............................................................................................................................ v
ABSTRACT ...............................................................................................................................................viii
LIST OF TABLES..................................................................................................................................... xiv
LIST OF FIGURES .................................................................................................................................................. xv
CHAPTER

1.

Ca 2+/Calmodulin-dependent protein kinase (CaMKII) role in long-term

memory through activation-triggered subunit exchange and holoenzyme stability.....1
1.1 Abstract..................................................................................................................................................1
1.2 Introduction ......................................................................................................................................... 1
1.3 The role of CaMKII in memory and learning .......................................................................... 2
1.4 Francis Crick's postulate of molecular memory ................................................................. 3
1.5 CaMKII as a candidate for memory molecule .......................................................................3
1.6 CaMKII structure and oligomerization ..................................................................................... 4
1.7 CaMKII Conclusions .......................................................................................................................... 5
2.

Activation-triggered subunit exchange in CaMKIIγ and CaMKIIδ ........................... 7
ix

2.1 Abstract.................................................................................................................................................. 7
2.2 Introduction ......................................................................................................................................... 7
2.3 CaMKIIα and CaMKIIβ activation-triggered subunit exchange ................................... 10
2.4 FRET assay to test homo-oligomeric and hetero-oligomeric subunit exchange for
CaMKIIγ ...................................................................................................................................................... 10
2.5 Single-molecule TIRF measuring hetero-oligomeric CaMKIIγ/CaMKIIα subunit
exchange .................................................................................................................................................... 11

2.6 Other variables inducing CaMKII subunit exchange ........................................................ 13
2.7 CaMKIIδ subunit exchange ......................................................................................................... 15
2.8 Conclusions ....................................................................................................................................... 15
2.9 Methods .............................................................................................................................................. 16
2.10 Acknowlegdements ..................................................................................................................... 21

3.

Characterzation of stability of CaMKIIα holoenzyme ................................................2 7
3.1 Abstract............................................................................................................................................... 27
3.2 Introduction ...................................................................................................................................... 28
3.3 CaMKII protein domain stability .............................................................................................. 30
3.4 Crystal structure of the CaMKII kinase domain ................................................................. 31
x

3.5 Analysis of CaMKII dissociation using mass photometry .............................................. 32
3.6 Conclusions ....................................................................................................................................... 34
3.7 Methods .............................................................................................................................................. 39
3.8 Acknowlegdements ....................................................................................................................... 43
4.

Studies of CaMKII oligomerization domain and holoenzymes in solution ........56
4.1 Abstract............................................................................................................................................... 56
4.2 Introduction ...................................................................................................................................... 57
4.3 CaMKII hub stoichiometry state and thermal stability ................................................... 59
4.4 CaMKII hub stoichiometry state may predict calcium sensitivity .............................. 60
4.5 CaMKII chimeras stoichiometry of hub is related to Ca2+ sentivity ........................... 60
4.6 Conclusions ....................................................................................................................................... 61
4.7 Methods .............................................................................................................................................. 62
4.8 Acknowlegdements ....................................................................................................................... 67

5.

Live-cell FLIM FRET using a commercially available system ..................................82
5.1 Abstract............................................................................................................................................... 82
xi

5.2 Introduction ...................................................................................................................................... 83
5.3 Principles of FLIM-FRET.............................................................................................................. 84
5.4 Equipment and materials ............................................................................................................ 87
5.5 Proof of concept 1 - CyclinB1-Cdk1 activity reporter in Drosophila S2 cells…. .... 89
5.6 Proof of concept 2 – Camui CaMKII sensor in human HEK293T

cells…….......................................................................................................................................................102

5.7 Utilizing the Nikon A1-FLIM platform ................................................................................ 104
5.8 Conclusions .................................................................................................................................... 105
5.9 Acknowledgments ...................................................................................................................... 106
6.

Future perspectives on CaMKII subunit exchange role in long-term memory

formation .............................................................................................................................................. 119
6.1 Overview ........................................................................................................................................ 119
6.2 CaMKII subunit exchange ........................................................................................................ 119
6.3 CaMKII holoenzyme stability ................................................................................................. 121
6.4 CaMKII oligomerization state ................................................................................................ 121
6.5 CaMKII FRET biosensor ........................................................................................................... 122
xii

6.6 Conclusions ................................................................................................................................... 122
APPENDIX: Activation-triggered subunit exchange in CaMKIIγ and CaMKIIδ.............123
BIBLIOGRAPHY.........................................................................................................................................................125

xiii

LIST OF TABLES

Table

Page

1.

PartslistandcostestimatesforthecompoundsofTCSPCFLIMsystem............................... 115

3.

Lifetime measurments of CyclinB1-Cdk1 reporters in proof of concept 1................117

2.
4.

Properties of fluorescent protein donors that exhibit mono-exponential decay....116
FRET efficiency measurments of soluble CyclinB1-Cdk1 reporters in prof of concept
1 ...................................................................................................................................................................118

xiv

LIST OF FIGURES

Page

Figure
1.

Figure 2.1 CaMKII protein domains and holoenzyme architecture .................................. 21

3.

Figure 2.3 CaMKII subunit exchange of homo-oligomeric CaMKIIα/CaMKIIα and
CaMKIIγ/CaMKIIγ using single-molecule TIRF . ........................................................................ 23

2.

4.
5.

6.

Figure 2.2 CaMKIIγ shows activation-trigerred subunit exchange with FRET bulk
assay ........................................................................................................................................................... 22

Figure 2.4 Hetero-oligomeric subunit exchange of CaMKIIα/CaMKIIγ with singlemolecule TIRF.......................................................................................................................................... 24

Figure 2.5 Biophysics of CaMKII subunit exchange ................................................................. 25

Figure 2.6 CaMKIIδ subunit exchange using FRET bulk assay . ........................................... 26

7.

Figure 3.1 CaMKII architecture ........................................................................................................ 45

9.

Figure 3.3 Crystal structure of the CaMKII kinase domain................................................... 47

8.
10.
11.

12.
13.

14.
15.
16.

17.

18.

Figure 3.2 Differential scanning calorimetry of CaMKII domains ..................................... 46
Figure 3.4 Mass photometry analysis of CaMKII variants..................................................... 48
Figure 3.5 DSC replicates .................................................................................................................... 49

Figure 3.6 Reorientation of the αD helix ...................................................................................... 50
Figure 3.7 Raw MP data: CaMKIIα hub ......................................................................................... 5 1
Figure 3.8 Raw MP data: CaMKIIα-30 ........................................................................................... 52

Figure 3.9 Raw MP data: CaMKIIα-0 .............................................................................................. 5 3
Figure 3.10 Size estimation of CaMKII variants from Mass Photometry ........................ 54

Figure 3.11 CaMKIIα oligomer dissociation. .............................................................................. 5 5
Figure 4.1 CaMKII protein domains and the four hub domains for the four CaMKII
variants. ..................................................................................................................................................... 68
xv

19.
20.

21.
22.

23.

24.

25.

26.

27.

28.
29.
30.
31.
32.
33.

Figure 4.2 CaMKII hubs in solutions show different stoichiometry and different
patterns of dissociation at the same concentration (100 nM) with mass photometry.69
Figure 4.3 CaMKIIα hub dilution from 100 to 70 nM using mass photometry. ........... 7 0
Figure 4.4 CaMKIIβ hub dilution from 100 to 70 nM using mass photometry............ 7 1
Figure 4.5 CaMKIIδ hub dilution from 100 to 70 nM using mass photometry............ 7 2
Figure 4.6 CaMKIIγ hub dilution from 100 to 70 nM using mass photometry............ 7 3
Figure 4.7 Differential Scanning Calorimetry for all four CaMKII hubs. ......................... 74

Figure 4.8 The replicates for DSC CaMKII hubs......................................................................... 76

Figure 4.9 CaMKIIβ hubs shows stoichiometry of 14-mer and a 16-mer... ................... 7 7
Figure 4.10 CaMKII holoenzyme stoichiometries using mass photometry... ................ 78
Figure 4.11 CaMKII holoenzymes stoichiometries using mass photometry
replicates.... ............................................................................................................................................... 79

Figure 4.12 CaMKII holoenzymes and CaMKII chimeras stoichiometries using mass
photometry are related to calcium sensitivity... ....................................................................... 80
Figure 4.13 CaMKII chimeras stoichiometries using mass photometry and
replicates... ................................................................................................................................................ 81

Figure 5.1 Schematic of how a decay curve is generated in the time-correlated single
photon counting (TCSPC) FLIM technique... ............................................................................ 107

Figure 5.2 Schematic showing how a single exponential decay donor behaves in the
absence of FRET and when engaged in FRET with an acceptor... ................................... 108

Figure 5.3 Layout of the FLIM system outlined in this methods chapter... ................. 109

34.

Figure 5.4 CyclinB1-Cdk1 FLIM-FRET reporter design... ................................................... 110

36.

Figure 5.6 Layout and principles of a phasor plot................................................................. 112

35.
37.

37.

Figure 5.5 Lifetime analysis using SPCImage software (Becker & Hickl).... ............... 111
Figure 5.7 FLIM-FRET data analysis and visual display using the phasor plot......... 113
Figure 5.8 Camui FLIM-FRET sensor for CaMKII activation.... ......................................... 114
xvi

CHAPTER 1

Ca2+/Calmodulin-dependent protein kinase II (CaMKII) role in long-term memory
through activation-triggered subunit exchange and holoenzyme stability

1.1 Abstract

Written by Torres-Ocampo Ana P.

Calcium/calmodulin-dependent protein kinase II is Thr/Ser kinase discovered in the

1970s. To date, behavioral and cellular data pointed to a possible role during Long-term
potentiation (LTP), the underlying cellular mechanism for memory formation. However, its

specific role remains ambiguous. How memory and learning work at the molecular level
remains unclear. Francis Crick proposed a postulate for a memory molecule that is the key
to escape a protein’s turnover. CaMKII fits all of his proposed criteria, and in this chapter, it
is summarized how CaMKII is a key molecular player in memory formation.
1.2 Introduction

While looking to understand better the regulation of bovine brain hormonal regulation

and their mechanism, calmodulin (CaM) was discovered to be the mediator for various
signaling processes (Cheung, 1969). Calmodulin is a 16.7 kDa protein that can bind up to
four calcium ions and is now widely known as a sensor for intracellular calcium that is

tightly regulated in order to maintain cellular homeostasis. It is crucial for the activity of
various kinases, ion receptors, among others (Takemoto-Kimura et al., 2017; Urrutia et al.,

2019). One of the kinases that require CaM/Ca2+ for its activity is calcium/calmodulindependent protein kinase II (CaMKII), described by Shulman and Greengard (Schulman &
Greengard, 1978).
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In the 40+ years since then, extensive research has shown that this oligomeric kinase

(Ahmad et al., 1982; Bhattacharyya et al., 2016; Chao et al., 2011; Fukunaga et al., 1982) has

been found in various human tissues and plays significant roles in each. CaMKII has four

genes in humans: α, β, γ, and δ. Historically, CaMKIIα and β are found in the brain and are

involved in memory and learning (Herring & Nicoll, 2016). CaMKIIγ has a preeminent role

during egg fertilization (Escoffier et al., 2016; Yoon et al., 2008), and CaMKIIδ is present in
cardiac muscle (Backs et al., 2009; Maier & Bers, 2002). CaMKII has four protein domains: it

has a kinase, regulatory segment, variable linker, and hub. The hub, or oligomerization
domain, oligomerizes the enzyme into dodecamers or tetradecamers that range from 500
kDa to 700 kDa. A CaMKII monomer is 50 kDa to 80 kDa depending on the linker length.

The nature of our research was to describe the biochemical and biophysical

properties of CaMKII. We wanted to understand how this might be related to its activity and

subunit exchange, a potential mechanism that might be involved in neurons during longterm memory formation (Bhattacharyya et al., 2016; M. Stratton et al., 2014)
1.3 The role of CaMKII in memory and learning

After CaMKII’s initial discovery, tremendous volumes of research started to

accumulate describing its potential roles. Giese and colleagues made an intriguing

observation where they showed how mice exhibit difficulty remembering and learning after

they mutate T286 to T286A, an important phosphorylation site for CaMKII. This mutation

inhibits CaMKII’s T286 autophosphorylation and subsequently the ability to gain calcium

autonomy in the absence of Ca2+ signaling (Giese et al., 1998). Along with T286, CaMKII also

has two other essential phosphorylation sites, T305 and T306. When mutated to
T305A/T306A, mice with these mutations also displayed learning and recalling deficiencies
in mice (Elgersma et al., 2002). This phenotype pointed to a significant role for CaMKII
during memory formation and learning.
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1.4

Francis Crick’s postulate of molecular memory
How are memories stored for years in our brains? The way memory and learning works

at the molecular and cellular level is still poorly understood. It is known that the main
drivers of cellular processes are proteins. However, a cell’s proteome is turned over in days,

at most weeks. Therefore, the question arises: How is information stored for years within
the cells if the proteins that orchestrate cellular processes are turned over much faster than
this? Francis Crick came up with a postulate about a memory molecule, most likely a

protein, that would be found in cells and would be the key to understanding how memory
works at the cellular and molecular level (Crick, 1984). Here are the 4 characteristics
proposed for a memory molecule:

1. Its activity is crucial for memory

2. Its activity is modulated by a post-translational modification
3. It is oligomeric

4. It can exchange subunits with newly synthesized protein and share its activation state
CaMKII fits all these criteria, as I will highlight below.
1.5 CaMKII as a candidate for memory molecule

CaMKII is clearly crucial for memory formation. Since its discovery, CaMKII was

associated with kinase activity (Yamauchi & Fujisawa, 1980) and later Miller and Kennedy

described the process by which CaMKII was being auto phosphorylated in Thr286 after
CaM/Ca2+ binding to the regulatory segment (Miller & Kennedy, 1986). Therefore, CaMKII

fits also the criterion that its activity is modulated by post-translational modification.
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From the study from Giese and colleagues (Giese et al., 1998), we know CaMKII has

a role during memory and learning. But apart from that, there are a several publications

highlighting CaMKII’s presence during LTP, the underlying cellular mechanism for memory
formation and learning (Lisman et al., 2002; Otmakhov & Lisman, 2012; Rossetti et al.,

2017a). Therefore, CaMKII fits the criterion for its activity being crucial for memory
formation.

There was vast evidence that CaMKII was an oligomeric complex (Goldberg et al.,

1996; Hoelz et al., 2003; Rellos et al., 2010; Rosenberg et al., 2005; Schulman & Greengard,
1978). Few laboratories had crystallized different protein domains of human CaMKII

(Bhattacharyya et al., 2016; Chao et al., 2010; McSpadden et al., 2019; Rellos et al., 2010;
Rosenberg et al., 2005; Torres-Ocampo et al., 2020). However, Chao and colleagues were the

first to solve the crystal structure of the intact CaMKII holoenzyme (Chao et al., 2011). This

opened the door to study its molecular structure in more detail. Therefore, CaMKII fits the
criterion of being an oligomeric complex.

Most recently, CaMKII was reported to undergo activation-triggered subunit

exchange (M. Stratton et al., 2014). It was reported that upon activation, CaMKII can
exchange subunits with other CaMKII holoenzymes, whether the other CaMKIIs are
activated or not. And most importantly, after exchanging CaMKII was able to pass it

phosphorylation state to the other previously unactivated CaMKIIs. This provides clues for a
possible mechanism that may be able to escape protein turnover since it will be able to have
a prolonged signal in the cell. Thus, CaMKII is an ideal candidate as a memory molecule
according to Crick’s postulate.

1.6 CaMKII structure and oligomerization
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Several labs have elucidated CaMKII oligomeric architecture. We know that CaMKII is a

dodecameric/tetrameric complex (Bhattacharyya et al., 2016; Chao et al., 2011). CaMKII is
one of the few oligomeric kinases that show this high ordered oligomerization state. Due to

this, CaMKII apart from being tightly regulated by Ca2+/CaM, it also has this extra step of
regulation for its kinase activity. CaMKII already exhibits such behavior. For example, it has
frequency-dependent activation in vitro and in vivo (Ardestani et al., 2019; M. M. Stratton et

al., 2013). This means that CaMKII responds to amplitude and frequency of calcium spikes

which in cells. Therefore, not only can CaMKII get autophosphorylated but also can finely
tune its kinase activity according to the calcium spikes it’s exposed to. This is a mechanism
that points out how tightly regulated CaMKII can be in the cell.

Furthermore, activation is highly cooperative (Chao et al., 2010; M. M. Stratton et al.,

2013), and the hub allosterically regulates kinase activity (Sloutsky et al., 2020). Finally,

subunit exchange is possible due to the oligomeric structure of CaMKII (Bhattacharyya et
al., 2016; M. Stratton et al., 2014). Nonetheless, we know very little on how CaMKII

oligomerizes and/or any Kd or Ka for the holoenzyme assembly. Studying the Kd and Ka is a

complex problem because data suggest they are in the low nM range and techniques that

have the resolution at this concentration are lacking (Bhattacharyya et al., 2016).

Understanding these biophysical details of this oligomeric complex will allow us to

understand more thoroughly how it regulates itself by this complex. Accordingly, it is
crucial to study how oligomerization occurs for CaMKII.

1.7

Conclusions

Over 40 years of research have poised us to study subunit exchange, the seemingly

last piece of the puzzle that would make CaMKII a great candidate for the memory molecule

postulate. Stratton and colleagues (Bhattacharyya et al., 2016; M. Stratton et al., 2014)
studied CaMKIIα and CaMKIIβ subunit exchange. Nonetheless, there are still many aspects
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that we still do not understand. Among them is subunit exchange in the other CaMKII genes
and how its high order oligomeric nature might regulate its own kinase activity.
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CHAPTER 2

ACTIVATION-TRIGERRED SUBUNIT EXCHANGE IN CAMKII GAMMA AND CAMKII
DELTA
Written by Torres-Ocampo Ana P., Lee Il-Hyung, Chambers James, Hacker Christina and
Stratton Margaret

I performed all of the experiments in each figure; I made all the figures and wrote the
manuscript.

2.1 Abstract

Ca2+/calmodulin dependent protein kinase II (CaMKII) is an oligomeric kinase that

goes through activated-triggered subunit exchange. After Ca2+/CaM binding to the
regulatory segment allows the phosphorylation of Thr286 and turns on CaMKII, CaMKII
goes through subunit exchange with other CaMKIIs and this allows CaMKII to spread its

phosphorylation state to previously inactive CaMKIIs. This permits a long-lasting signal of

CaMKII activation. Previously, this process had been characterized in CaMKIIα and CaMKIIβ.
However, CaMKII has two other variants, CaMKIIγ and CaMKIIδ. This body of work presents
evidence that these two variants also go through subunit exchange by using a FRET bulk

assay and a single-molecule TIRF approach. Lastly, an ATP analog was used to interrogate

the activation-triggered mechanism of subunit exchange, and these data suggest an
unknown role for ATP during CaMKII subunit exchange.
2.2 Introduction

Ca2+/calmodulin dependent protein kinase II (CaMKII) is an oligomeric Ser/Thr
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kinase involved in many critical Ca2+ dependent signaling cascades throughout the body

(Backs et al., 2009; Herring & Nicoll, 2016; Yoon et al., 2008). Each subunit of CaMKII is

organized as a kinase domain, regulatory segment, linker, and hub domain (oligomerization

domain) (Fig 2.2A). There are four CaMKII genes in humans: α, β, γ, and δ. CaMKIIα and
CaMKIIβ are canonically implicated in the context of memory formation and learning
(Herring & Nicoll, 2016a). CaMKIIγ has an important role in egg fertilization (Yoon et al.,
2008), and CaMKIIδ has a crucial role in muscle cardiac tissue (Backs et al., 2009).

CaMKII has peculiar conformation as a dodecamer/tetradecamer kinase (Fig. 2.2b)

(Bhattacharyya et al., 2016; Chao et al., 2011; Sloutsky et al., 2020) due to the hub domain.
Several papers study how the hub confers remarkable properties to CaMKII. CaMKII has

frequency-dependent activation in vitro and in vivo, high cooperativity, and activationtriggered subunit exchange (Ardestani et al., 2019; M. Stratton et al., 2014; M. M. Stratton et

al., 2013). Activation-triggered subunit exchange has been previously studied in CaMKIIα
and CaMKIIβ (Bhattacharyya et al., 2016; M. Stratton et al., 2014). Therefore, the focus of

this paper will be expanding our knowledge of CaMKII activation-triggered subunit

exchange to the other two CaMKII variants: CaMKIIγ and δ.

Stratton et al. showed with Fluorescence Resonance Energy Transfer (FRET) and

single-molecule Total Internal Reflection Fluorescence (TIRF) experiments that once

CaMKII is activated (by adding ATP, Mg2+, Ca2+/calmodulin), it can exchange subunits with
other CaMKIIs that are active or inactive (M. Stratton et al., 2014). Therefore, subunit

exchange causes a spread of activation state to the other CaMKIIs (Figure 2.2A). Molecular

details of CaMKII activation-triggered subunit exchange of this mechanism are described in
(Bhattacharyya

et

al.,

2016).

Succinctly,

CaMKII

becomes

active

by

Thr286

autophosphorylation after Ca2+/CaM binds to the regulatory segment. After the calcium

signal fades, CaM dissociates and allows the phosphorylation on Thr305/306 and blocking
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CaM rebinding. The regulatory segment docks in the hub and destabilizes the vertical

interface of the hub and allows the release of a dimeric unit that can interact and exchange
with another CaMKII (M. Stratton et al., 2014).

CaMKII has a critical role during Long-Term Potentiation (LTP), which is the delicate

strengthening of the connection between neurons (Herring & Nicoll, 2016). LTP has been

appointed as the cellular cascade responsible for memory formation and learning in

hippocampal neurons (A. Lynch, 2004). Once activated during LTP, CaMKII binds to the Nmethyl-D-Aspartate (NMDA) receptor and phosphorylates various substrates (Bayer et al.,

2001; Opazo et al., 2010; Shifman et al., 2006; W. Zhang et al., 2019). The question becomes,

how are LTP and CaMKII activation-triggered subunit exchange possibly connected?

Neurobiologists are still struggling to explain how memories are stored for long periods of
time. CaMKII needs Ca2+/CaM initially to become active; however, once the Ca2+ stimulus

subsides in the cell, CaMKII could hypothetically remain active by exchanging with newly
synthesized CaMKII, thereby escaping protein-turnover. This property could be the key to
understanding how memory and learning work at the molecular level since it is known that

proteins in cells last days to weeks. However, it remains unknown if CaMKII activation-

triggered subunit exchange also has a role during LTP.

mRNA transcripts for all four CaMKII genes have been found in human hippocampal

neurons (Sloutsky et al., 2020). CaMKIIα and CaMKIIβ are in high abundance. Interestingly,
many CaMKIIγ and CaMKIIδ variants are also present (Sloutsky et al., 2020). This suggests
that all four CaMKIIs are there in protein form in the neurons as well, although, further

studies need to be done to confirm this. Furthermore, there is evidence that CaMKIIγ

regulates the expression of genes during LTP via the phosphorylation of transcription factor

CREB (Ma et al., 2014). This led to the study of activation-triggered subunit exchange in
CaMKIIγ and CaMKIIδ. Our results show that CaMKIIγ exchanges with itself and with
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CaMKIIα. We also study the biophysics of subunit exchange and activation-triggered subunit
exchange in CaMKIIδ.

2.3 CaMKIIα and CaMKIIβ activation-triggered subunit exchange
As mentioned above, there is evidence for activation-triggered subunit exchange in

CaMKIIα and CaMKIIβ. Stratton et al. reported that CaMKIIα could exchange with itself

using a FRET bulk assay and single-molecule TIRF. Moreover, Bhattacharyya et al.
(Bhattacharyya et al., 2016) reported that CaMKIIβ could exchange with itself and with
CaMKIIα to form hetero-oligomers. The half-times of the exchange events were calculated,

and we found that CaMKIIα/CaMKIIα subunit exchange was 20 minutes while

CaMKIIβ/CaMKIIβ was 22 minutes. CaMKIIα/CaMKIIβ had a half-times of ~30 minutes.

This suggests that the hetero-oligomeric subunit exchange is slower compared to homooligomeric subunit exchange (Fig 2.2D). Thus, CaMKIIγ and CaMKIIδ were tested since their
exchange properties are unknown.

2.4 FRET assay to test homo-oligomeric and hetero-oligomeric subunit exchange for
CaMKIIγ
Following protocol with the previous publication, we used fluorescent dyes with a

maleimide handle to label CaMKII. The CaMKIIγ variant used is (14, 17, 18b) and has a 57-

residue linker, according to the naming scheme proposed by Sloutsky et al. (Sloutsky &

Stratton, 2020). From now on, it will be called CaMKIIγ since it is the only CaMKIIγ used
here. Using the bulk FRET assay, active and unactivated samples of CaMKIIγ were tested.

For both samples, CaMKII labeled with red dye was mixed with CaMKII labeled with green
dye. For the active sample, ATP, Mg2+, and Ca2+/CaM were added. For the unactivated
sample, buffer was added to achieve the same final volume. For the homo-oligomeric

exchange, it was observed that CaMKIIγ/CaMKIIγ displays an increasing FRET ratio when

activated over time when compared with the inactive sample (Fig2.2B). For the hetero-
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oligomeric subunit exchange, CaMKIIγ was mixed with CaMKIIα (14,18) with a 30-residue

linker, which we call CaMKIIα from now on because it is the only CaMKIIα variant used

here. This also showed the same trend that the active sample has a higher FRET ratio over
compared to the inactive sample (Figure 2.2C). However, it is clear that the FRET ratio was

not as high as the homo-oligomeric FRET for CaMKIIγ/ CaMKIIγ. Despite the fact that all
CaMKII variants have 90% identity in the kinase and 75% in the hub and G470C was

mutated for optimal FRET signal, it seems that minor differences in structure in both
variants might have contributed to not getting a similar FRET ratio like the homo-

oligomeric subunit exchange. It might also point to the fact that hetero-oligomeric exchange
is just slower in general because of structural differences in both holoenzymes.

The half-times were calculated and for CaMKIIγ/CaMKIIγ exchange it was 18 mins (details

in methodology). For CaMKIIγ/CaMKIIα it was 56 mins (Figure 2.2D). This shows the same

trend as CaMKIIα and CaMKIIβ, where the homo-oligomeric exchange seems to be faster
than the hetero-oligomeric exchange (Figure 2.2D). In order to confirm the results and show

that they were not an artifact of aggregation, the next step was to test CaMKIIγ subunit
exchange using single-molecule TIRF.

2.5 Single-molecule TIRF measuring hetero-oligomeric CaMKIIγ/CaMKIIα subunit
exchange
The protocol from Stratton et al. (M. Stratton et al., 2014) single-molecule TIRF approach

was used for this experiment. Briefly, the CaMKII constructs have a C-terminal AviTag

(Howarth & Ting, 2008). CaMKII was biotinylated during the bacterial expression

(confirmed by mass spectrometry, A1). Once CaMKII has been purified from the bacterial
lysate and labeled with the fluorescent dyes, we compared an activated sample (ATP, Mg2+,

and Ca2+/CaM) to an inactivated sample (just buffer added) over time. A sample of each
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condition is added to a previously functionalized coverslip with PEG-PLL and PEG-biotin.
Streptavidin was then added at single-molecule density in order to get a visualization of
each CaMKII molecule separately (Figure 2.4A). Lastly, TIRF was used to image and take a

time course of both conditions (active and inactive CaMKII). During the analysis, firstly, a
Gaussian fit in each channel selects the labeled CaMKII holoenzyme. Then, the labeled
CaMKII holoenzymes in the same location in both channels would be considered co-

localized and, we interpret this as subunit exchange. In other words, red and green dyes
located within one CaMKII molecule (Figure 2.4B).

Multiple experiments using CaMKIIγ revealed irreproducible data. Over time, we observed

that each single particle was reduced in brightness and there was also evidence of
aggregated particles that were above our brightness threshold. This observation of
decreased brightness led us to question whether CaMKIIγ was dissociating at the low

concentrations required for these single molecule experiments (Figure 2.3A and B). Various
troubleshooting approaches were used, but no reproducible data was collected likely due to
stability issues of CaMKIIγ.

When compared with a CaMKIIα/CaMKIIα homo-oligomeric exchange, the single-molecule

TIRF experiment not bulk FRET, it was evident that CaMKIIγ does not behave as well as
CaMKIIα in the conditions at which the single-molecule experiment is performed. In order
to image single molecules, the CaMKII sample needs to be at nanomolar concentrations
during the experiment. Therefore, it was concluded that CaMKIIγ is not suitable for this

experiment. [See Chapter 3 for a detailed study of CaMKII holoenzyme stability (TorresOcampo et al., 2020).]

We attempted a different approach to the single molecule experiment to observe

hetero-oligomeric exchange between CaMKIIγ and CaMKIIα. Due to potential dissociation
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issues, the AviTag and linker on the C-terminus of CaMKIIγ was deleted, but it was retained

on CaMKIIα (Figure 4C). CaMKIIγ was labeled with Alexa 594 (red) and CaMKIIα-AviTag
was labeled with Alexa 488 (green). Only CaMKIIα-AviTag would be affixed to the surface

through interaction with streptavidin, so the observance of any red particles would indicate

that CaMKIIγ had exchanged into a CaMKIIα particle. After ~40 minutes, and we could very
clearly see in the active sample the appearance of many red molecules (211 molecules). The
inactive sample had fewer visible red molecules (25 molecules)(Figure 2.4C).

This data supports our previous FRET bulk data in which shows the hetero-oligomeric

exchange of CaMKIIγ/CaMKIIα. A complete time course of the experiment still needs to be

completed. For the CaMKIIγ/CaMKIIγ homo-oligomeric exchange experiment, other
approaches need to be found to test that in another way that does not include diluting
CaMKIIγ to nanomolar concentrations, like mass spectrometry or ultracentrifugation.
2.6 Other variables inducing CaMKII subunit exchange

After investigating the exciting dynamic of CaMKIIα and CaMKIIγ during subunit

exchange, interrogating the biophysics of subunit exchange was something to investigate
further. To date, the data support a model in which subunit exchange is activation-triggered.

A higher FRET ratio and a higher level of co-localization in active samples of CaMKII is

observed. In the unactivated samples, minimal subunit exchange is observed
(Bhattacharyya et al., 2016; M. Stratton et al., 2014). The standard setup for this experiment

is adding CaMKII to a final concentration of 5-8 uM and adding ATP 400 uM, Ca2+/CaM 6 uM,

Mg2+ 8 mM. For the unactivated, it is just the holoenzyme at the same final concentration

and buffer.

Thus, in order to test if exchange is facilitated specifically by ATP, a FRET bulk assay was

used where ATP was replaced with ATP-γS, a non-hydrolyzable analog of ATP. Surprisingly,
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we observed subunit exchange in this sample as well when compared to an active sample

(Figure 2.5A and B). Other conditions were tested as well, including ATP-γS + Mg2+ with no

Ca2+/CaM present, and Ca2+/CaM + Mg2+. Since CaM is not present in these samples, CaMKII

should not be active and hence not exchange. In the condition with no ATP present, we also
don’t expect CaMKII activation because of ATP absence. Additionally, no background

phosphorylation was happening during the expression or purification by doing a western
blot for pThr286. We did not detect any phosphorylated Thr286 (A2). Notably, some

amount of subunit exchange was detected in all the conditions tried.

As possible explanation for this is that the ATP binding pocket regulates subunit

exchange independent of activation. When half-times were calculated, a significant

difference was not observed between conditions (Figure 5B). However, when comparing
the last time point of the time course, its clear that they have different ratios suggesting that
there is still exchange, but something is different (Figure 2.5C).

These experiments shed light on the biophysical properties of CaMKII subunit exchange.

Moreover, it shows how much still remains to understand of this process. In order to tease
out more of these results, we need do the corresponding single-molecule experiments.
2.7 CaMKIIδ subunit exchange

We wanted to test all CaMKII genes; therefore, we also tested CaMKIIδ. Our previous

experiments with CaMKIIα construct had a linker and a C-terminal AviTag (Howarth & Ting,

2008). For CaMKIIδ, we did include the C-terminal AviTag, and, interestingly, we did not
observe subunit exchange with itself. However, when we mixed this construct with CaMKIIα

with the C-terminal AviTag, we did observe subunit exchange. This piece of data is very
encouraging because it is the first evidence showing subunit exchange for CaMKIIδ.
However, additional experiments need to be done to confirm subunit exchange within the
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CaMKIIδ/CaMKIIδ exchange (single-molecule TIRF) and study more thoroughly how the Cterminal AviTag is affecting subunit exchange and CaMKII dynamics.
2.8 Conclusions

This study was seeking to expand the scope of CaMKII subunit exchange. It was

previously shown subunit exchange with CaMKIIα and CaMKIIβ. However, after a few

recent publications (Sloutsky et al., 2020) and (Ma et al., 2014), it was time to interrogate if
CaMKII subunit exchange is possible in the other CaMKII genes with the previous setup

used with bulk FRET and single-molecule TIRF (M. Stratton et al., 2014). CaMKII subunit

exchange presents an ideal model for persistent activation in neurons, a mechanism that
might be the link to understand long-term memory. Therefore, this publication expands the
understanding of CaMKII subunit exchange into CaMKIIγ and CaMKIIδ genes. Hence, in this

publication, it is reported that CaMKIIγ can exchange with itself and with CaMKIIα. CaMKIIδ
seems to exchange with CaMKIIα but not with itself. The role of the AviTag needs to be
studied more carefully.

In order to understand more details about how subunit exchange works, it was

investigated by using our FRET bulk assay by adding ATP variants. It was observed that

activation might not be necessary for subunit exchange, somewhat an allosteric binding of
the ATP pocket, which opens the door to more exciting questions and significantly changes

the model of how it was thought that CaMKII subunit exchange works. There is evidence
that allostery has a role in CaMKII regulation of kinase activity by the hub (Sloutsky et al.,

2020). This was surprising because it was always thought that the hub was just a protein
domain responsible for oligomerization. However, with the data presented, it is observed

that the kinase domain may affect CaMKII holoenzyme dynamics by occupying the ATP

pocket. This study is just beginning to understand how CaMKII is regulated by allostery in

various ways. It is crucial to have a solid understanding of CaMKII subunit exchange in vitro
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before transferring our studies to neurons and interrogating the possible importance of

CaMKII subunit exchange during LTP or other long-term memory-derived mechanisms in
neurons.

2.9 Methods
Molecular Biology

Human CaMKII constructs for all CaMKII genes used in this study. They were cloned

into a pSMT3 vector with an N-terminal HisSUMO tag (LifeSensors Malvern, PA). The

CaMKII variants that have no linker were deleted using Inverse PCR. The point mutations
for the FRET labeling were done using QuickChange (Agilent Technologies, Santa Clara, CA).

All CaMKIIs used in this study had the following numbering: CaMKIIα (7-475, C290S, C298S,

D365C, Δ473-475), CaMKIIδ (1-445, Δlinker, C298S, D335C) and CaMKIIγ (1-445, Δlinker,

C298S, D335C).

Protein expression and purification

We used an ÄKTA Pure system for all of the protein purification described below at

4 °C. We used the protocol described previously (Torres-Ocampo et al. 2020). Briefly, we

used Tuner (DE-3) pLysS cell with an added plasmid with λ phosphatase. The cells were
grown

until

OD600

0.4-

0.6

and

then

induced

with

1

M

isopropyl

β-D-1

thiogalactopyranoside (IPTG) and grown overnight at 18 °C. Cells were pelleted and

resuspended in Buffer A (25 mM Tris. 150 mM KCl, 40 mM Imidazole 10% Glycerol and 1

mM TCEP pH 8.5) plus (0.5 mM Benzamidine, 0.2 mM AEBSF, 0.1 mg/mL trypsin inhibitor,

0.005 mM Leupeptin, 1 μg/mL Aproptinin, 1 μg/mL Pepstatin) plus 1 μg/mL DNAse, and
then lysed. Then, clarified lysate was run through a 5 mL Ni-NTA column and eluted with

0.5 M Imidazole. Fractions were pulled together and desalted into Buffer C (25 mM Tris. 150

mM KCl, 40 mM Imidazole, 10% Glycerol, and 2 mM TCEP pH 8.5) and left overnight at 4 °C
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to be cleaved by Ulp1. The sample was then loaded into Q-FF 5 mL column and eluted with a

KCl gradient. The cleanest fractions were pooled together, concentrated, and loaded on to
Superpose 6 gel-filtration equilibrated with 25 mM Tris, 150 mM KCl, 1 mM TCEP, and 10%

glycerol pH 8.0). Samples were subsequently labeled and frozen at -80 °C or just directly
frozen.

Labeling CaMKII with fluorescent dyes

CaMKIIα (7-475, C280S, C289S, D365C, Δ473-475) had a C-terminal AviTag

(Howarth and Ting 2008) followed by a GASGASGAS linker. CaMKII was biotinylated during

bacterial expression. Therefore, CaMKII was followed by labeling with Alexa Fluor C5Maleimide 488 (Cat#A10254, Thermo Fischer) or Alexa Fluor C5-Maleimide 594

(Cat#A10256, Thermo Fischer). Each dye was resuspended in 25 mM Tris pH 8.0 and had a

final concentration of 8 to 5 mM. CaMKII was mixed individually with each dye for a 3x
molar excess of dye and left at room temperature for 1.5 to 2 hrs. Labeled CaMKII was

desalted into PD-25 columns (Product#28918007, GE Healthcare) with gel filtration buffer

(25 mM Tris, 150 mM KCl, 1 mM TCEP 10% glycerol) to get rid of excess dye. Samples were

then concentrated using Amicon filters to a final subunit concentration of 40-30 μM, flash
frozen and kept at -80 C. We calculated labeled protein concentration using spectra analysis
(Nanodrop, Thermo Scientific, DE).

First, we measured CaMKII protein concentration using A280. The extinction

coefficients

for

all

CaMKII

constructs

were

calculated

using:

http://web.expasy.org/protparam/. For each dye, A280 was measured as well as their
respective spectra for each dye. The extinction coefficient for the Alexa dyes used: 488 ε =

73,000 cm-1 M-1 and 594 ε = 92,000 cm-1 M-1. Labeled protein was scanned after desalting,
and A280 was corrected for dye contribution. Labeling efficiency was calculated by
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[dye]/[protein]. Our labeling efficiencies were 40-80%. A double labeled CaMKII was made

as previously described by adding both dyes at the same time. Final protein concentration
and labeling efficiency were calculated as the means of both dyes.
FRET experiments

For each FRET experiment, labeled CaMKII was mixed to a final concentration of 10-

6 μM. To activate CaMKII, we added MgCl2 [8 mM], Ca2+/calmodulin [6 μM], ATP [400 μM]

final concentration. Inactive CaMKII was just mixed and diluted with gel filtration buffer.

After both samples were mixed, active and inactive, they were incubated at 37 °C or 25 °C.

Each time point a sample form the active and inactive were taken to a final concentration of

1 or 0.5 μM in a 20 μL 384 well plate (Corning Cat#3820) and each reading was taken in a
Synergy H1 microplate reader (Biotek). A 500-700 nM spectrum was acquired for each time
point and experiments were done in triplicates.
Calculation of FRET ratio

FRET ratio was calculated by dividing the emission fluorescence (621 nm) of the

acceptor divided by the emission of the donor (521 nM). Then, we plotted that value to see

how the ratio increased or not, over time.

Calculation of half-times for FRET bulk assay

Prism: “One-way ANOVA followed by Dunnett’s multiple comparisons test was

performed using GraphPad Prism version 8.0.0 for Windows, GraphPad Software, San
Diego, California USA, www.graphpad.com”.

KaleidaGraph: Nonlinear curve fit was performed using KaleidaGraph version 4.5.4 for
Windows, Synergy Software, Reading, PA, USA. www.synergy.com.
Single molecule
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Functionalization of Coverslips

Coverslips were functionalized using PEG-PLL and PEG-Biotin (SuSoS AG) as

previously described (Stratton et al 2014). Briefly, round glass (Fisher brand
cat#12545102) were sonicated for 30 mins in 1% Helmanex III (article # 9-307-011-4-

507), rinsed with ddH2O and sonicated for 30 mins with 1:1 ddH2O and isopropanol. The

coverslips were rinsed ddH2O and dried. The circular coverslips holders (Thermo Fisher

cat#A7816) were cleaned the same way. Then, the coverslips were cleaned for 5 mins in
Harrick Plasma PDC-001 plasma cleaner and assembled into the circular holders.

Immediately after, we added the 0.25 mL of PEG-PLL and PEG-Biotin (1 mg/mL; 500:3 ratio
of the two solutions by volume, SuSoS AG). Incubated for 30 mins at and then washed

carefully with 1 mL of imaging buffer. Just before experiment, Streptavidin (Molecular
Probes) was added to a final concentration of 0.1 mg/mL and incubated at 25 °C for 10 mins
and then washed carefully with imaging buffer 7 times.
Mixing experiments

We activated CaMKII as previously described. In order to image at single-molecule

resolution, CaMKII was diluted to 5-8 nM concentrations and then added to the

functionalized coverslip, let it incubate for 1 min and then washed with imaging buffer.
Microscope settings

Single-particle fluorescence imaging was done using the NSTORM/TIRF microscope

housed in the UMass IALS Light Microscopy Facility. A total of 10 images randomly chosen
1024x1024 pixel fields of view (164 × 164 μm) were imaged on each coverslip using the
488 nm laser at 1% and 561 at 15% power with an exposure time of 500 ms. Using the

Nikon 100X Plan Apo TIRF objective and a Hamamatsu sCMOS camera with a TIRF angle of
60.7.
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Co-localization Calculation

After images were acquired, we analyzed with a script written by Dr. Il-Hyung Lee

using MATLAB and Statistics Toolbox Release 2012b, The MathWorks, Inc., Natick,

Massachusetts, United States. Briefly, each image needs to get converted to tiff file in each

channel. They were identified the same name for each time point as A or B, for example
picture number 10, for red channel is 10a and for green channel is 10b. Then, a difference of

Gaussian (DoG) is used for each molecule. Lastly, a second analysis with coordinates

produced by prior analysis to c-localize molecules in both channels. We filtered out by using
a 1-2.5 pixel cutoff to differentiate really close molecules vs co-localized molecules.
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Figure 2.1. CaMKII protein domains and holoenzyme architecture. A) CaMKII protein

domains: kinase, regulatory segment, linker region and hub domain. B) CaMKII holoenzyme
cartoon depiction of a dodecamer/tetradecamer and visualization of a CaMKII dimer.
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Figure 2.2. CaMKIIγ shows activation-triggered subunit exchange with FRET bulk
assay. A) Schematic of how subunit exchange works. B) CaMKIIγ/CaMKIIγ homo-oligomer

shows higher FRET ratio over time (squares, purple) over inactive sample (circles, purple).
C) CaMKIIγ/CaMKIIα hetero-oligomer shows the same trend, active (squares, green) vs

inactive (circles, green). D) Shows calculated half-times for each FRET experiment, homooligomers and hetero-oligomers.
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Figure 2.3. CaMKII subunit exchange of homo-oligomeric CaMKIIα/CaMKIIα and
CaMKIIγ/CaMKIIγ using single-molecule TIRF. A) CaMKIIα/CaMKIIα subunit exchange
comparing 0 mins vs 90 minutes. In both time points, both look similar in amount of

molecules imaged and intensity in fluorescence. B) CaMKIIγ/CaMKIIγ subunit exchange 0

mins vs 90 minutes. Fewer molecules are observed at timepoint 0 mins and at 90 minutes,

there is almost no molecules left and there is a trend of very bright molecules and very dim
molecules compared to the 0 mins timepoint.
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Figure 2.4. Hetero-oligomeric subunit exchange CaMKIIγ/CaMKIIα with singlemolecule TIRF. A) Set up for the functionalized coverslips with PEG-PLL and PEG-

Biotin with single-molecule density streptavidin. CaMKII holoenzymes with an AviTag

attached to the coverslip and later imaged with TIRF. B) Snapshot of data collected for
the time course for CaMKII subunit exchange, both CaMKIIs with an AviTag C)

Schematic of CaMKIIγ with no AviTag and CaMKIIα with AviTag. Meaning, subunit

exchange is being measured through the attachment of CaMKIIα to the functionalized

coverslip. Time point 0 minutes and 40 minutes are shown.
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Figure 2.5. Biophysics of CaMKII subunit exchange. A) FRET bulk assay with ATP

analogs. B) The half-times calculated for the each condition in the FRET bulk assay. C)

Normalized values of the last time point for the FRET-bulk assay, 105 mins, comparing all

conditions. Although, the half-times are similar there are differences in percentage of ratio.

A double-labeled sample was used as 100% exchanged sample (gray) and the active sample
was (green) was ~82 %. The other conditions ATP-γS + Ca2+/CaM + Mg 2+ (dark blue) , ATPγS + Mg 2+ (pink) and Ca2+/CaM + Mg 2+ (light blue) have ~75% or less.
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Figure 2.6. CaMKIIδ subunit exchange using FRET bulk assay. A) CaMKIIδ/CaMKIIδ
with no linker. Both conditions, active and inactive, show no subunit exchange B)

CaMKIIδ/CaMKIIα, CaMKIIδ with no linker/no AviTag and CaMKIIα with a 30-residue linker
and AviTag, the active condition shows subunit exchange.
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CHAPTER 3

CHARACTERIZATION OF STABILITY OF CAMKII ALPHA HOLOENZYME
As written by Torres-Ocampo Ana P., Özden Can, Hommer Alexandra, Gardella Anne,

Lapinskas Emily, Samkuttty Alfred, Esposito Edward, Garman Scott C. and Stratton Margaret
M.

As published in Protein Science in 2020

I collected all mass photometry measurements and made the figures for that. Wrote,
analyzed data and conceptualized manuscript.

3.1 Abstract
Ca2+/calmodulin dependent protein kinase II (CaMKII) is a Ser/Thr kinase necessary

for long-term memory formation and other Ca2+ dependent signaling cascades such as
fertilization. Here, we investigated the stability of CaMKIIα using a combination of

differential scanning calorimetry (DSC), X-ray crystallography and Mass Photometry
(MP). The kinase domain has a low thermal stability (apparent Tm = 36 °C), which
is slightly stabilized

by

ATP/MgCl2 binding (apparent Tm =

40 °C),

and

significantly

stabilized by regulatory segment binding (apparent Tm = 60 °C). We crystallized the kinase
domain of CaMKII bound to p-coumaric acid in the active site. This structure reveals

solvent-exposed hydrophobic

residues

in

the

substrate-binding

pocket,

which

are normally buried in the autoinhibited structure when the regulatory segment is

present. This likely accounts for the large stabilization we observe in DSC measurements
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comparing the kinase alone to the kinase plus regulatory segment. The hub domain alone is

extremely

unfolding

stable (apparent Tm ~90 °C), and the

transitions

ranging

from

holoenzyme

~60 °C -

structure

100 °C. Using

MP,

has

we

multiple

compared

a CaMKIIα holoenzyme with different variable linker regions and determined that the

dissociation of both these holoenzymes occurs at a higher concentration (is less

stable) compared to the hub domain alone. We conclude that within the context of the
holoenzyme structure, the kinase domain is stabilized whereas the hub domain is
destabilized. These data support a model where domains within the holoenzyme interact.
3.2 Introduction

Ca2+/calmodulin dependent protein kinase II (CaMKII) is a Ser/Thr kinase known to be

a central signaling molecule in many systems throughout the body. In humans, CaMKII is

encoded by four

separate

are found predominantly in

genes:

neurons

CaMKIIα, β,
and

play

γ

a

and

δ.

crucial

CaMKIIα

role

in

and

β

long-term

memory formation (Herring & Nicoll, 2016b; Rossetti et al., 2017b) CaMKIIδ is expressed in
cardiomyocytes and contributes to cardiac pacemaking (Backs et al., 2009; T. Zhang et al.,

2007). CaMKIIγ is found throughout the body in smooth muscle, skeletal muscle and

elsewhere, and also plays an essential role in eggs during fertilization (Escoffier et al., 2016;

Yoon et al., 2008). All CaMKII genes are comprised of four domains: kinase, regulatory

segment, variable linker region, and hub (Figure 2.1A). The kinase domain and regulatory

segments are >90% identical between the four genes and the hub domains are >75%

identical. CaMKII is activated by Ca2+/calmodulin (Ca2+/CaM) competitively binding

to the regulatory segment and dislodging it from the substrate-binding site, making the

pocket accessible. The structure of CaMKII has recently been reviewed (Bhattacharyya et al.,

2019).
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The hub domain of CaMKII is responsible for oligomerization. In this series of experiments,
we

will

focus

on human CaMKIIα

specifically. The

CaMKIIα hub

domain

alone (Bhattacharyya et al., 2016) and the CaMKIIα holoenzyme (Chao et al., 2011) were

both crystallized as dodecameric assemblies. There is agreement in recent studies using

both single

particle negative

stain and cryo-electron microscopy (EM) that auto

inhibited CaMKIIα holoenzymes form both dodecamers and tetradecamers t(Bhattacharyya

et al., 2016; Myers et al., 2017; Sloutsky et al., 2020). There is evidence from the full-length

CaMKIIα (with no variable linker) crystal structure (Chao et al., 2011) and single particle

cryo-EM (Sloutsky et al., 2020) that the kinase domains directly contact the hub domain.

The hub domain organizes the kinases into an oligomeric conformation,

which confers

several

unique

biophysical

properties

to

the

enzyme including

highly cooperative and frequency-dependent activation, and activation-dependent exchange

of subunits between holoenzymes. CaMKII activation is highly cooperative, where binding
of one Ca2+/CaM potentiates adjacent subunits to bind Ca2+/CaM, likely due to interactions
between subunits within the holoenzyme ring (Chao et al., 2010; Gaertner et al., 2004;

Rosenberg et al., 2005). It has been shown in vitro that CaMKII has a threshold frequency

for activation; meaning that above a specific frequency of Ca2+, CaMKII will turn on, but
below this frequency it will remain off (Bayer et al., 2002; Chao et al., 2011; Paul &

Schulman, 1998). Stochastic kinetic simulations suggest that this frequency response is a

product of the rates of kinases binding to the hub domain, Ca2+/CaM binding to the

regulatory segment, and Thr286 transphosphorylation (Chao et al., 2011).

CaMKII activity biosensors, Camui (Takao et al., 2005) and FRESCA (FRET sensor for

CaMKII activity) (Ardestani et al., 2019), have been used to monitor CaMKII activity in

response to Ca2+ oscillations in live cells. These studies indicate that also in vivo, CaMKII

activation

is

cooperative and

varies
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depending

on

the

frequency

of

Ca2+ delivered (Ardestani et al., 2019; J. Y. Chang et al., 2019). Finally, Ca2+/CaM binding and

subsequent phosphorylation of Thr286 results in autonomous CaMKII activity and induces

exchange of subunits between holoenzymes (Bhattacharyya et al., 2016; M. Stratton et al.,

2014). Significant evidence supports a mechanism where the regulatory segment interacts

with the hub domain, resulting in the release of a vertical dimer unit, which can then

assemble into a nearby CaMKII holoenzyme (Bhattacharyya et al., 2016; M. Stratton et al.,
2014).

Structural regulation of CaMKII activity appears to depend on the combination of

variable linker and hub identity. In CaMKIIα, completely removing the variable linker

region makes the enzyme much harder to activate (i.e., requires more Ca2+/CaM for
activation) (Chao et al., 2011; Sloutsky et al., 2020). Intriguingly, attaching a CaMKIIα kinase

domain to the hub domain of CaMKIIβ with no linker makes the enzyme easier to activate
(Sloutsky et al., 2020). Little is known about the assembly or disassembly of CaMKII

holoenzymes, other than the assertion that the vertical dimer is likely the unit of subunit
exchange, and possibly also the unit of assembly. Motivated to further understand how the

multiple

domains

of

CaMKII

influence

one

another

from

a

biophysical

perspective, herein we focus on understanding the stability of the CaMKIIα holoenzyme.

3.3

CaMKII protein domain stability

We employed

differential

scanning

calorimetry

(DSC)

to

measure the thermal stability of CaMKIIα domains in order to dissect how each domain

affects the overall stability of the holoenzyme (Fig. 3.2, 3.5). We separately measured the

melting temperatures of the kinase domain, kinase domain with regulatory segment, hub
domain, holoenzyme with no linker and holoenzyme with a 30-residue linker

(CaMKIIα(14,18). The nomenclature (CaMKIIα(14,18) designates that this variant of

CaMKIIα includes exons 14 and 18, which results in a 30-residue linker. For simplicity, since
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we are only using two variants of CaMKIIα, we will refer to these as CaMKIIα-0 (no linker
version) and CaMKIIα-30 (30-residue linker. The transcripts of both of these variants are
found in human hippocampus (Sloutsky et al., 2020)

We first measured the kinase domain alone, and the maximum temperature of

unfolding was 36 °C (Fig. 3.2A). Adding the regulatory segment to the kinase domain
stabilized it by a remarkable 24 degrees (apparent Tm = 60 °C). The hub domain alone was

extremely stable, with the majority of the sample unfolding at 90 °C. There is an additional
transition that is stabilized by ~8 degrees (apparent Tm = 98). Fusing the kinase domain to

the hub domain with no variable linker region (CaMKIIα-0) results in a transition very
similar to that of the kinase domain plus regulatory segment (apparent Tm = 57 °C) (Fig.

3.2B). In the presence of a 30-residue disordered variable linker region (CaMKIIα-30), there
is a small stabilization by 2 degrees (apparent Tm = 59 °C).

Both CaMKIIα-0 and CaMKIIα-30 had additional transitions that are approximately

the same maximum temperature of unfolding as the hub domain alone (Fig. 3.2C). These

transitions had significantly lower enthalpy (∆H) compared to the major transition around

56-58 °C. CaMKIIα-30 has an additional transition (Tm = 81 °C) with a similar ∆H as the
most stable transition (Tm = 93 °C) (Fig. 3.2B).
3.4

Crystal structure of the CaMKII kinase domain

We crystallized the CaMKII kinase domain with an inactivating mutation (D135N) and

lacking the regulatory segment (Figure 3.3, PDB: 6VZK). In the structure, the ATP binding

site is occupied with p-coumaric acid, which was present in the silver bullet additive in our
screen. ATP binding stabilizes the kinase domain by 4 °C (Tm = 40 °C) (Fig. 3.3B). The

benzene ring of p-coumaric acid mimics where the adenine base of ATP would be oriented.

The carboxylic acid tail of p-coumaric acid is in close contact with K42 (2.87 Å) and
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D156 (3.34 Å). This lysine (K42 in CaMKIIα) is highly conserved among protein kinases to

facilitate ATP binding, specifically phosphate group orientation (Gibbs & Zoller, 1991;
Knighton et al., 1991). The hydroxyl group of p-coumaric acid is in contact with
the backbone of V92 (3.27 Å and 2.85 Å).

In its auto inhibited state, the helical CaMKII regulatory segment occupies the substrate

binding site (PDB: 2VZ6) (Rellos et al., 2010). This binding pocket on the kinase domain
contains

several hydrophobic residues,

which

interact with

L290 on

regulatory

segment, protecting these residues from the solvent (Rellos et al., 2010) (Fig. 3.3C). While

F98, I101 and I205 residues are completely buried, V102 is only partially buried as one

gamma carbon atom is still exposed. In the absence of the regulatory segment, these

hydrophobic residues are solvent exposed, shown in our structure (Fig. 3.3D). Similar to

the active conformation (PDB: 2WEL (Rellos et al., 2010)), the αD helix reorients toward

where the regulatory segment was bound (Fig. 3.6). This movement of the αD helix leaves

the hydrophobic amino acid patch unoccupied, resulting in complete exposure to

the solvent (Fig. 3.3D).

3.5

Analysis of CaMKII dissociation using mass photometry

We employed mass.photometry (MP) to analyze the dissociation of CaMKII oligomers(Y

oung et al., 2018). We measured the molecular weight (MW) of single molecules of CaMKII

in solution over a concentration range to determine the concentration at which CaMKII

oligomers dissociate. We used MP to compare the CaMKIIα hub domain alone to the full-

length holoenzyme with and without a variable linker region (CaMKIIα-30 and CaMKIIα-0,
respectively) over a concentration range of 100 nM to 45 nM (subunit concentration) (Fig.

3.4, for raw count profiles see Fig. 3.7-3.9). For all replicates, we observed populations of
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molecules at high MW values (200-600 kDa). For most samples, we also observed the clear

emergence of a population of molecules at low MW values (50-200 kDa).

The hub domain was the best-behaved sample across all concentrations tested (Fig.

3.4A, 3.7). At 100 nM subunit concentrations, there was a clear major population of

molecules with an average MW of 239±2 kDa, which corresponds roughly to a 16mer (hub

subunit = 15.3 kDa). This large oligomeric species was still intact even at 45 nM. The size

distribution of large hub oligomers is centered on 16-18 subunits per molecule at these

concentrations (Fig. 3.10A). At all concentrations except 90 nM, there was an additional

population of molecules at a lower MW (~80-100 kDa). The ratio of molecules in the high
MW

population

compared

fold) across all samples.

to

low

MW

population

remained

high

(22-

Both versions of the CaMKII holoenzyme tested were less stable than the hub

domain alone (Fig. 3.4B and 3.4C). At concentrations of 90-100 nM, CaMKIIα-30 had a major

population of molecules at a high MW: 519±23 kDa, which roughly corresponds to

a 10mer (CaMKIIα-30 subunit = 53.1 kDa) (Fig. 3.10B). At these same concentrations,

CaMKIIα-0 also had

a

major

population of

molecules at a

high

MW: 606±50 kDa,

which roughly corresponds to a 12mer (CaMKIIα-0 subunit = 50.4 kDa) (Fig. 3.4C, 3.10C).

CaMKIIα-30 and CaMKIIα-0 showed an increase in the number of low MW molecules

across

the

dilution

series. For CaMKIIα-30, the low MW population was

100 nM, and increased relative

to

the

high

MW

evident

at

population at the

lowest concentrations tested (45 and 60 nM). The majority of the low MW species were

roughly 95 - 245 kDa, corresponding to a dimer - pentamer. Similarly for CaMKIIα-0, the

low MW population increased at 75 nM and continued to increase at the lowest

33

concentrations tested (60 and 45 nM). The majority of the low MW CaMKIIα-0 species

were 77 - 151 kDa, corresponding to a monomer/dimer – trimer.

From our MP measurements, we summed the total number of molecules within specific

MW ranges consistent with the size of larger oligomers (Fig.3.11, see Materials and

Methods for calculation details). For the hub domain samples, the percentage of high MW

molecules does not change over the concentration range we tested. This indicates that
the Kd for the hub domain alone must be lower than that of the holoenzyme. For CaMKIIα-

30 and CaMKIIα-0, there is a clear increase in the percentage of high MW molecules over
this concentration range, indicating that we are sampling near the Kd.
3.6 Conclusions

It has been known that CaMKII is a large protein assembly since 1983, when it was

determined to be a dodecamer (Bennett et al., 1983). However, there is still little known
about the assembly and disassembly of CaMKII, including estimates for Kd. This has been a

difficult question to tackle due to technical limitations in addition to indirect evidence
suggesting CaMKII oligomerization must have a very low Kd. Our stability measurements

combined with mass photometry shed new light on this old problem.

Our DSC data show that the hub domain alone is extremely stable, with the majority

unfolding around 90 °C (Fig. 3.2). The second transition has a 2.5 fold lower ∆H
and is stabilized to 100 °C. This transition is reproducible between all samples,
which may represent a final unfolding transition such as monomer unfolding. Further
experiments are needed to fully elucidate this. Conversely, the kinase domain
is thermally unstable, with the majority unfolding around 36 °C. This is similar to that
measured for Mitogen Activated Protein kinase (Krishna et al., 2013).
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Addition of the regulatory segment to the CaMKII kinase domain results in a
remarkable 26 °C stabilization. Our crystal structure of the CaMKII kinase domain shows
several hydrophobic residues (F98, I101, V102, I205) that are solvent exposed in the
absence of the regulatory segment (Fig. 3.3). This is likely an entropic cost that accounts
for the stability difference we observe. This hydrophobic pocket is largely responsible for
substrate

binding;

further

experiments

would

be

needed

to

test

whether

substrate binding (or inhibitors such as CaMKIINtide) results in a similar stability
shift. The crystals were obtained without any nucleotide added, however, an additive (pcoumaric acid) was resolved in the ATP-binding site. As we suspected, and is true for
other kinases (Bauer et al., 2019), ATP/MgCl2 binding stabilizes the kinase domain
by 4 °C (Fig. 3.3B). Adding MgCl2 without ATP may also have an effect on stability,
which will be tested in future studies.
CaMKII holoenzyme stability falls in the middle of these two domains, indicating
significant interactions and influence between domains within the oligomer.
For CaMKIIα-30 and CaMKIIα-0, the first large transition around 56 °C (~40-60 kJ/mol)
is likely the kinase domains unfolding. Included in this transition may also be
dissociation of the hub domain into dimers. The second and third unfolding transitions,
which produced a smaller heat release (~10-15 kJ/mol), may indicate the unfolding of
hub dimers, or intact hub domains with unfolded kinase tails. Interestingly, the first
transition is comparable between CaMKIIα-30 and CaMKIIα-0 whereas the right-shifted
transitions are not exactly overlapping (Fig. 3.2C). This may indicate that the 30residue variable linker region additionally destabilizes the hub domain to induce
unfolding of some hub domains at a lower temperature (transition 2, 81 °C).
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Structures of the human hub domains have revealed both 6-fold and 7-fold
symmetries, forming dodecamers or tetradecamers (Bhattacharyya et al., 2016; Rellos et
al., 2010; Rosenberg et al., 2006). More recently, CaMKII hub-like domains from green
algae have been shown to assemble into 16-20mers (McSpadden et al., 2019). In our MP
measurements with human CaMKIIα hub, the high MW population roughly corresponds
to a 16mer. It is clear that this oligomeric complex is very stable since it does not
dissociate significantly at 45 nM (Fig. 4A, S7). Though, it is clear that at 45 nM that
additional populations are increasing in the sample, suggesting that we are approaching
the Kd. Further experiments are needed to determine whether these hubs are actually
forming 16mers at these concentrations and also to determine the Kd.
Structures of human CaMKII holoenzymes have also revealed both 6-fold and 7-fold
symmetries (Bhattacharyya et al., 2016; Chao et al., 2011; Myers et al., 2017; Sloutsky et
al., 2020) The crystal structure of CaMKIIα-0 showed a dodecamer with all the kinases
docked onto the hub domain (Chao et al., 2011). Cryo-EM studies of CaMKIIα30 showed that both stoichiometries are adopted, in addition to populations where the
kinase is docked onto the hub domain in different orientations (Sloutsky et al., 2020). In
our MP measurements of CaMKIIα-0, the high MW population corresponds to
12mer/14mer, which is consistent with existing data. For CaMKIIα-30, we observe a high
MW population corresponding to 10mer/12mer. Decameric CaMKII assemblies have
been observed in solution-based anisotropy measurements (Sarkar et al., 2017) and
negative stain EM (Kanaseki T, Ikeuchi Y, Sugiura H, 1991). Since CaMKIIα-30 has a
disordered region and likely leads to a myriad of possible conformations for all kinase
domains, this flexibility may affect the contrast used to calculate MW in the
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interferometric scattering microscopy (iSCAT) method. It is also unknown how dilution
may affect oligomerization, since all structural studies are done at significantly higher
concentrations by necessity. Regulation and implication of CaMKII stoichiometry is still
largely not understood and will be the focus of future studies.
As CaMKII dissociates into smaller oligomers, interfaces that are normally buried
must become solvent exposed. The solubility of these species is likely low. We suspect
that the low MW molecules we measured are underrepresenting what is present in the
solution due to adsorption to other surfaces, or aggregation. In order to calculate the Kd, it
will be necessary to screen for conditions that stabilize these dissociated species but do
not interfere with the contrast optics of the MP setup. In this way, an accurate number of
low and high MW molecules can be calculated at equilibrium. However, our
measurements indicate that CaMKII dissociation may be cooperative. This is most
evident in the CaMKIIα-0 dilution series where the high MW population clearly starts to
shift to 1-2 low MW populations (Fig. 3.4C). Perhaps as CaMKII dissociates it
preferentially forms dimers and tetramers, as has been predicted from subunit exchange
experiments, discussed below. The MP data are not as clear for CaMKIIα-30, which may
either be because the dissociation kinetics are different, or because the variable linker
region further destabilizes the released subunits, resulting in noisy measurements. As
mentioned above, there is a hint of hub destabilization seen in the DSC measurement of
CaMKIIα-30, where there is a transition at a lower Tm (81 °C) compared to CaMKIIα0. Stabilizing these species will help us clarify this.
Based on our measurements, we have roughly estimated Kd values of ~1020 nM for CaMKII oligomerization. These new data have clear implications on
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understanding the mechanism of CaMKII subunit exchange (Bhattacharyya et al., 2016;
Singh & Bhalla, 2018; M. Stratton et al., 2014). The concentration of holoenzymes in
dendritic spines is estimated to be 100 µM (Otmakhov & Lisman, 2012), indicating
that complete dissociation of oligomers on a reasonable timescale in spines is
unlikely. As previously discussed, the proposed mechanism for subunit exchange relies
on holoenzyme activation by Ca2+/CaM followed by induced release of a vertical dimer
by interaction between the regulatory segment and hub domain. Future MP experiments
measuring active CaMKIIα will indicate whether activation also affects dissociation, and
thereby potentially facilitates subunit exchange.
Importantly, subunit exchange measurements were largely performed using
single-molecule fluorescence measurements (M. Stratton et al., 2014). The concentration
of CaMKII used during the exchange experiments was ~5 µM. In order to make the
single-molecule measurement, the sample was diluted to ~2 nM, affixed to a glass
surface, and imaged. Given that this dilution is slightly below the apparent Kd, the total
number

of

exchange

events

may

have

been underestimated due

dissociation under these conditions. However, in

order to

further

to

dissect

some
this,

future MP experiments will be geared towards taking time points under equilibrium
conditions to determine the rate of dissociation.
Both the DSC and MP measurements suggest that the kinase and hub domain
influence one another and do not behave like beads on a string. This is in line with
structural studies showing interactions between the kinases and the hub domain (Chao et
al., 2011; Sloutsky et al., 2020). Additionally, when comparing kinase activity between
CaMKIIα and CaMKIIβ with no linker, there are significant differences in EC50 value for
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Ca2+/CaM, indicating that different structures are being adopted (Sloutsky et al., 2020). It
is logical that these two covalently linked domains have evolved ways to
interact (Kuriyan & Eisenberg, 2007).
It will be interesting to test the remaining three CaMKII variants in terms

of temperature stability and dissociation parameters. There are sufficient differences

between the hub domain sequences (>80% identical) that may provide changes in
oligomerization kinetics and stability. This may have further implication on understanding
mixed oligomers, which are known to exist in the brain (Shen et al., 1998), and likely exist in

other tissues as well.
3.7 Methods

Molecular biology

The WT CaMKIIα kinase, CaMKIIα kinase + regulatory segment and

both CaMKIIα holoenzymes (with and without linker) were cloned into a vector
containing an N-terminal His-SUMO tag. The CaMKIIα hub was cloned into a pET-28
vector with an N-terminal 6xHis-precission tag using Gibson assembly.
Protein purification

WT CaMKIIα kinase

domain (residues 7-274,

with

and

without

D135N) and CaMKIIα kinase + regulatory segment (residues 7-314) were grown

and co-expressed in E. coli BL21 with λ phosphatase. The cells were induced at

18 °C with 1 mM Isopropyl β- d-1-thiogalactopyranoside (IPTG) and grown

overnight. The cells were then suspended using Buffer A (25 mM Tris, pH 8.5, 150

mM KCl, 40 mM imidazole, 10% glycerol), commercially available protease
inhibitors (0.5 mM Benzamadine, 0.2 mM AEBSF, 0.1 mg/mL trypsin inhibitor, 0.005
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mM Leupeptin, 1 μg/mL aproptinin, 1 μg/mL pepstatin) plus 1 μg/mL DNAse.
Purification was done at 4 °C using utilizing a ÄKTA Pure system (GE). Clarified
lysate was loaded onto a Ni-NTA column and eluted with an imidazole gradient,
desalted into Buffer C (25 mM Tris pH 8.8, 50 mM KCl, 40 mM imidazole, 2 mM

TCEP, 10% glycerol) and cleaved overnight with Ulp1 at 4 °C. Following a
subtractive step, the sample was then bound to a HiTrap Q FF column (GE) and

eluded with a KCl gradient. Samples were concentrated and further purified and

desalted using a Superdex 75 column into DSC buffer (25 mM Tris pH 8, 150

mM KCl, 1 mM TCEP, and 10% glycerol). The pure protein was then frozen and
stored at -80 °C.

CaMKIIα-0 (7-475,

Δ324-354) and CaMKIIα-30

(7-475)

were

co-expressed

with λ phosphatase using Rosetta (DE-3)pLysS cells. They were purified as
previously described. Holoenzymes were purified using a Superose 6 column
(GE). All purified holoenzymes eluted consistently (retention volume 12 mL).

Retention volumes were consistent with standards as well as other samples, which
have been verified as holoenzymes using cryo-electron microscopy.

The CaMKIIα hub domain (residues 315-475) was expressed in BL21 cells

and purified as described except a different Buffer C (25 mM Tris pH 8.8, 150
mM KCl,

1

mM

EDTA,

2

mM

DTT,

10

%

glycerol) to

facilitate Prescission protease cleavage overnight at 4 °C. Samples were eluted from

the Superose 6 column into DSC buffer. All purified hubs eluted consistently
(retention volume 14 mL). Pure protein samples were frozen and stored at -80 °C.
Differential Scanning Calorimetry
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All protein samples were diluted to 0.5 mg/mL in DSC buffer (25 mM Tris pH

8, 150 mM KCl, 1 mM TCEP, 10% glycerol). DSC measurements were performed on
a MicroCal Automated PEAQ-DSC instrument (Malvern Panalytical, Westborough,

MA). For the CaMKIIα kinase + ATP/MgCl2, ATP (1 mM) and MgCl2 (10 mM)

were used and added to the buffer blank as well. Unless otherwise indicated, after a

5 min pre-scan equilibration step, samples were scanned from 10-120 °C at a scan

rate of 90 °C/hr with no feedback. Data were analyzed using MicroCal PEAQ-DSC

software, and baseline-subtracted data were fit to a non-two-state fitting model to
obtain apparent Tm values.

Crystallization, data collection and structure determination

Crystals of CaMKII kinase domain (residues 7-274) with an inactivating

mutation (D135N) were grown at 4 °C using hanging drop vapor diffusion. An

additional mutation in this structure is Q223K, which was acquired during the

cloning process. This residue is solvent-exposed on the αG helix, and comparing this
structure to previous structures with Q223 shows no effect on the fold or
orientation. Crystals were obtained in the following condition: 8% PEG 6000, 50 mM

HEPES, pH 7.0 and H10 condition of the Silver Bullets screen (1:10 ratio) containing:
0.16% w/v 3-Aminobenzene-sulfonic acid; 0.16% 5-Sulfosalicylic acid dihydrate;
0.16%

w/v

p-Coumaric

acid;

0.16%

PIPES;

0.16%

Terephthalic

acid;

0.16% Vanillic acid; Buffer 0.02 M HEPES pH 6.8. The crystal was cryo-protected in
20% (v/v) ethylene glycol prior to being frozen in liquid nitrogen. Diffraction data

were collected at a wavelength of 1.5418 Å using a Rigaku MicroMax-007 HF X-ray
source, which was coupled to a Rigaku VariMax HF optic system (UMass Amherst).
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The X-ray data were collected at 100 K. Data sets were integrated, merged and
scaled using HKL-2000 (Otwinowski & Minor, 1997). The structure was solved by

molecular replacement (MR) with Phaser (McCoy et al., 2005) using the coordinates
of the kinase domain as an initial search model (PDB ID: 3SOA (Chao et al.,

2011)). Model building was performed using (Emsley & Cowtan, 2004)Coot and
refinement was performed with REFMAC (Winn et al., 2003).
Mass Photometry

All MP experiments were carried out using an OneMP mass photometer

(Refeyn LTD, Oxford, UK) at room temperature and used Acquire MP software for

data collection. Coverslips (cat #630-2105) were cleaned by rinsing with a series of
H2O, ethanol, and isopropanol (HPLC grade), and then dried under a clean stream of

nitrogen. Gaskets (catalog #CW-50R-1.0) were cleaned using H2O and ethanol, then
dried under nitrogen. The gasket was then sealed onto the center of the glass
coverslip. The coverslips were stored in a sterile container until used. 10 µl of buffer

(25 mM Tris, 150 mM KCl and 1 mM TCEP at pH 8.0) was added to the coverslip and
focused. Images were collected in an area of 3 x 10 µm at a frame rate of 1
kHz. Protein stock solutions (2 µM) were diluted to 200 nM (25 mM Tris, 150

mM KCl and 1 mM TCEP at pH 8.0) right before the experiment. Proteins were
further diluted to achieve the following concentrations in the measurements:
100 nM, 90 nM, 75 nM, 60 nM and 45 nM. Three replicates were performed at each

concentration. Collection time was varied to acquire the same number of binding
events over the dilution series. Since the technical limit of the instrument at low MW
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is 50 kDa, we will not be able to fully resolve monomeric hub subunits
(15.3 kDa) (Wu & Piszczek, 2020)
MP Data Analysis

DiscoverMP software was used for all analyses using standard settings. Each

replicate was analyzed individually. Only molecules that bound to the glass surface

were

counted.

Populations

were

automatically

fit

with

a

Gaussian

distribution (Young et al., 2018). For these populations, the mean Gaussian values

from replicates were averaged to calculate an average MW, these values are
reported ± the standard deviation between three replicates. Some low MW

populations could not be fitted for a Gaussian distribution due to insufficient
sampling of multiple populations. In order to quantify the relative number of low vs.

high MW species in the total number of molecules, we established MW cutoffs in line
with replicates where low and high MW populations were Gaussian distributed.

The MW ranges for low and high MW species used are as follows. CaMKIIα-hub:

low = 14-161 kDa; CaMKIIα-0: low = 50-400 kDa, high = 400-800 kDa; CaMKIIα-30:

low = 50-300 kDa, high = 400-800 kDa. These ranges were applied to the following

samples. CaMKIIα-hub: low = 90, 75, 60 45 nM; CaMKIIα-0: low = 100, 90, 60 nM,
and one replicate of 45 nM, high = 45 nM; CaMKIIα-30: low = 90, 75, 60 nM, 45 nM,
high = 45 nM. For all other samples, the number of molecules was defined by the
Gaussian fit.
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Figure 3.1 CaMKII architecture. (a) Linear depiction of the CaMKII subunit organization.
Domain colors are consistent throughout the figure. (b) Ca2+/calmodulin competitively

binds the regulatory segment to expose the substrate‐binding pocket and activate the
enzyme. This allows for Thr286 to be trans‐phosphorylated. (c) Cartoon depictions of the

hub domain alone, CaMKIIα‐0 (compact conformation), and CaMKIIα‐30 (extended
conformation). CaMKII, Ca2+/calmodulin‐dependent protein kinase II.
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Figure 3.2 Differential scanning calorimetry of CaMKII domains. Representative traces

are shown as well as the average apparent Tm rounded to the nearest integer calculated
from all replicates (see replicate data sets in Figure 3.5). (a) From left to right: overlays of
CaMKIIα kinase domain without (gray) and with (purple) regulatory segment and the

CaMKIIα hub only (burgundy). (b) Overlays of CaMKIIα‐0 (blue) and CaMKIIα‐30 (green).
(c) Overlays of all traces for comparison. CaMKII, Ca2+/calmodulin‐dependent protein
kinase II.
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Figure 3.3 Crystal structure of the CaMKII kinase domain. (a) Kinase domain alone
crystallized bound to p‐coumaric acid. Inset (bottom) highlights residues coordinating p‐

coumaric acid. (b) DSC comparing kinase alone with no ATP or MgCl2 (gray, shown in
Figure 2a) to kinase domain plus 1 mM ATP/10 mM MgCl2 (orange). (c) Crystal structure of
kinase domain plus regulatory segment (PDB: 2VZ6). Hydrophobic residues on the kinase

domain (dark blue, labeled in 3D) are buried by the regulatory segment, specifically
interacting with L290 (cyan). Surface representation is shown below at a 90° rotation. (d)
Hydrophobic residues on the kinase domain (dark blue) are solvent exposed. Surface

representation is shown below at a 90° rotation. CaMKII, Ca2+/calmodulin‐dependent
protein kinase II; DSC, differential scanning calorimetry.
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Figure 3.4 Mass photometry analysis of CaMKII variants. Overlays of three replicates for

each concentration measured (100, 90, 75, 60, and 45 nM) are shown for CaMKIIα‐hub (a),
CaMKIIα‐30 (b), and CaMKIIα‐0 (c). Density is plotted against mass (kDa). Raw counts were
converted to kernel density, which is used to better depict multistep processes. CaMKII,
Ca2+/calmodulin‐dependent protein kinase II.
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Figure 3.5. DSC replicates
The raw data and corresponding fits for all DSC replicates are shown. Apparent Tm values

are listed for all observed transitions. A) kinase domain alone, B) hub domain alone, C)
CaMKIIα-0, D)CaMKII-30, E) kinase + regulatory segment, F) kinase + ATP/MgCl2.

Figure 3.6. Reorientation of the αD helix
Overlay of the crystal structures of kinase domain alone (magenta) and kinase

domain plus regulatory segment (gray) where the regulatory segment has been

removed for clarity. The αD helix shifts outward by ~18°, indicated by the arrow.
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Figure 3.7. Raw MP data: CaMKIIα hub
Replicates for CaMKIIα-hub at each concentration: 100 nM, 90 nM, 75 nM, 60 nM and 45 nM.
Total counts (# molecules) are plotted against mass (kDa).
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Figure 3.8. Raw MP data: CaMKIIα-30
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Replicates for CaMKIIα-30 at each concentration: 100 nM, 90 nM, 75 nM, 60 nM and 45 nM.
Total counts (# molecules) is plotted against mass (kDa).

Figure 3.9. Raw MP data: CaMKIIα-0
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Replicates for CaMKIIα-30 at each concentration: 100 nM, 90 nM, 75 nM, 60 nM and 45 nM.

Total counts (# molecules) is plotted against mass (kDa).

Figure 3.10. Size estimation of CaMKII variants from Mass Photometry
The X-axis from the raw data sets (Fig. S3-S5) was converted to number of subunits.
We set mass ranges for the size of a CaMKII dimeric unit (110 kDa for holoenzymes,
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30 kDa for the hub domain) and then calculated the number of molecules within these
ranges (plotted on the Y-axis as counts).

Figure 3.11. CaMKIIα oligomer dissociation. The percentage of high MW molecules (large
oligomer species) is shown over a concentration range for the hub alone, CaMKIIα-30 and

CaMKIIα-0.

55

CHAPTER 4
Studies of CaMKII oligomerization domain and holoenzymes in solution
Torres-Ocampo Ana P. Özden Can, Samkutty Alfred, Flaherty Daniel, Esposito Edward and
Stratton Margaret M.

I performed all mass photometry experiments, made all the figures, analyzed data,
4.1 Abstract

conceptualized and wrote manuscript.

Ca2+/calmodulin dependent protein kinase II (CaMKII) is an oligomeric complex

required for memory formation and other cellular cascades in the body. The CaMKII

holoenzyme has a kinase domain, regulatory segment, and hub domain that allows it to
oligomerize into a 12-mer or 14-mer. The hub domain alone has been structurally

characterized as a 12-mer, 14-mer, and 16-mer. In comparison, the CaMKII holoenzyme is
a12-mer and 14-mer. Using mass photometry (MP) and differential scanning calorimetry
(DSC), the hub domain dissociation pattern was correlated to its thermal stability. It was

observed that with a lower melting temperature, there was higher dissociation of the hub

domain. The CaMKII holoenzyme size was correlated to its degree of Ca2+ sensitivity at the
same concentration. CaMKII holoenzymes that were 14-mer were shown to have a lower
Ca2+ sensitivity while 12-mer had a higher Ca2+ sensitivity. Surprisingly, the CaMKII

chimeras holoenzymes also confirmed that the hub domain determines the size of the

holoenzyme and predicts Ca2+ sensitivity. This study is the first characterization of CaMKII
oligomerization in solution and how this may regulate dissociation and Ca2+ sensitivity.
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4.2 Introduction
Ca2+/calmodulin dependent protein kinase II (CaMKII) is a Ser/Thr oligomeric

kinase. CaMKII has a kinase domain, regulatory segment and hub or oligomerization domain
(Fig 4.1A) CaMKII has four genes in the human body: CaMKIIα, CaMKIIβ, CaMKIIγ and

CaMKIIδ. CaMKII is crucial to several organs in the body, including brain, eggs, and heart

muscle (Backs et al., 2009; Herring & Nicoll, 2016a; Yoon et al., 2008). Historically, CaMKIIα

and CaMKIIβ are implicated in memory formation (Herring & Nicoll, 2016a). However,

there are mRNA expression profiles in hippocampal neurons derived from all four variants.

(Sloutsky et al., 2020). There is evidence that CaMKIIγ and CaMKIIδ are involved in
neuronal signaling pathways (Ma et al., 2014; Zalcman et al., 2019). Moreover, mutations in
neuronal CaMKIIδ show severe intellectual disabilities phenotypes in humans (unpublished
data, Geeske M.van Woerden). This opens up the question about the specific roles of each
CaMKII in neurons and the calcium driven cellular cascades there.

If all four CaMKII are present in neurons, how are they regulated, and how can it be

teased out which CaMKII is participating in what pathway? One possibility is by looking at

their EC50 for Ca2+/CaM. The EC50 is a measurement of required Ca2+/CaM for half-maximal

activation for CaMKII. CaMKII holoenzyme requires Ca2+/CaM for activation so that Thr286

can be auto-phosphorylated and turn one kinase activity. Consequently, in a previous

publication, the EC50 for Ca2+/CaM for each CaMKIIα and CaMKIIβ and their corresponding

splicing variants were elucidated. (Sloutsky et al., 2020). The EC50 of CaMKIIγ and CaMKIIδ

with no linker were also reported. Surprisingly, it was observed that EC50, or Ca2+ sensitivity,

tracked with the hub evolutionary divergence (Sloutsky et al., 2020). CaMKIIα (EC50 = 313

nM) and CaMKIIδ (EC50 = 167 nM) are closely related and showed a similar EC50 (these

measurements were done with a no linker variant). CaMKIIβ (EC50 = 21 nM) and CaMKIIδ
(EC50 = 28) are closely as well and also showed a similar EC50. CaMKII chimeras, α kinase β
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hub, and β kinase α hub were also tested, and their EC50 measurement helped reveal an
allosteric role for the hub for kinase activity. CaMKII α kinase β hub showed an EC50 = 24 nM

and CaMKII β kinase α hub showed an EC50 =102 nM. This means that despite the CaMKII

kinase domain that the CaMKII hub is attached to, the CaMKII hub regulates EC50.

This finding was quite surprising because the hub is known for being the

oligomerization domain of the CaMKII holoenzyme but somehow its also regulating kinase
activity. This led us to study the oligomerization state of the CaMKII hub and CaMKII

holoenzyme and interrogate if its also involved in regulating kinase activity. The
oligomerization states of CaMKIIα holoenzymes and the hub domain alone have been
measured using mass photometry (Torres-Ocampo et al., 2020). Mass photometry is a

technique that allows measuring a macromolecule molecular weight with high accuracy in
solution (Young et al., 2018). The CaMKIIα hub domain in solution was more stable in

comparison with the CaMKIIα holoenzymes, which dissociated into dimers at lower
concentrations (Torres-Ocampo et al., 2020). Thus, we took advantage of mass photometry

and studied the stoichiometry all four CaMKII hubs and their corresponding holoenzymes
(no linker variants were used).

So far, all the studies analyzing the stoichiometries of CaMKII hubs and CaMKII

holoenzymes are not in solution but instead are from crystal structures, cryo-EM, and
negative stain EM (Bhattacharyya et al., 2016; Buonarati et al., 2021; Chao et al., 2011;

Myers et al., 2017) Here, we present stoichiometry data of all four CaMKII hubs and

holoenzymes in solution. Differential scanning calorimetry (DSC) was used to compare

thermal stability to stoichiometry. Two CaMKIIβ hub crystal structures are presented,

showing 14 and 16-mer architectures. Our findings expand our understanding of CaMKII

oligomerization in solution and how it relates to kinase activity, which might shed light on
how CaMKII is regulated in cells and their Ca2+ regulated pathways.
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4.3

CaMKII hub oligomerization state and thermal stability
The stoichiometries of all four CaMKII hubs were tested at 100 nM (Fig 4.1B). To

estimate the size of each hub oligomer, the molecular weight of a CaMKII hub monomer was
used, which is ~15 kDa. Consequently, a 14-mer falls within the range of ~210 kDa, and a

16-mer falls under ~240 kDa. Notably, it was found that CaMKIIα hub (218 kDa ± 30 kDa)

and CaMKIIγ hub (226 ± 43.2 kDa)) hubs are mainly 14-mers whereas CaMKIIβ hub (251 ±

19.4 kDa) and CaMKIIδ hub (251 ± 52.5 kDa) are 16-mers. (Figure 4.2A). This in contrast

with a CaMKIIα hub crystal structure, which showed a stoichiometry of a 12-mer
(Bhattacharyya et al., 2016). CaMKIIγ hub crystal structure showed the stoichiometry of a

12-mer and CaMKIIδ hub crystal structure showed a stoichiometry of a 14-mer (Rellos et
al., 2010). There is no previous CaMKIIβ hub crystal structure reported.

When the mass photometry measurements are acquired, peaks in different

populations are observed. Curiously, for CaMKIIβ hub and CaMKIIγ hub showed fewer

smaller species compared to CaMKIIα hub and CaMKIIδ hub at the same concentration
(Figure 4.2B). Big species are referred as the 14-mer or 16-mer detected and, small species

are referred to as species 150 kDa or below. In order to examine if this was a trend, all four
hubs were measured at 90 nM, 80 nM, and 70 nM (Figure 4.3-4.6). Then, for each

concentration, the number of small species were divided by the big species observed that
indeed, over the range of concentration tested, CaMKIIβ hub and CaMKIIγ has a fewer
smaller species versus CaMKIIα hub and CaMKIIδ hub has more big species (Figure 4.2B).

Driven by this observation, we compared the melting temperatures (Tm) of the hubs using
DSC. We observed that CaMKIIβ hub (Tm = 110 °C) and CaMKIIγ hub (Tm = 102 °C) had
significantly higher stabilities compared to CaMKIIα hub (Tm = 90 °C) and CaMKIIδ hub (Tm

= 82 °C) (Figure 4.7A).
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Lastly, we solved two crystal structures of the CaMKIIβ hub showing two

stoichiometries: 14-mer and 16-mer. This also highlights the importance mass photometry
as it allows us to study CaMKII molecules in solution, which may behave differently

compared to crystallography conditions where the protein is highly concentrated (Figure
4.8).
4.4

CaMKII hub stoichiometry may predict calcium sensitivity
After looking at the CaMKII hubs, looking at the CaMKII holoenzymes became a

point of interest. To estimate size for the CaMKII holoenzyme, the size of the CaMKII

holoenzyme monomer was used, which is ~50 kDa. Thus, a 12-mer is ~600 kDa and a 14-

mer is ~700 kDa. All the holoenzymes tested had no linker between the regulatory segment
and hub. CaMKIIα holoenzyme was (620 ± 69.7 kDa), making it a 12-mer. For the rest of the
CaMKII holoenzymes, we observed the following: CaMKIIβ (703.3 ± 44 kDa), CaMKIIδ (664

kDa ± 64 kDa) and CaMKIIγ (701 kDa ± 50 kDa). This means these are 14-mers (Figure 4.9-

4.10).

Interestingly, a very striking observation was made. As previously mentioned, the

EC50 for Ca2+/CaM of the CaMKII holoenzymes (with no linker) had already been reported

(Sloutsky et al., 2020). When comparing those values, it seems that the 12-mer (CaMKIIα)

needs more Ca2+/CaM (EC50 = 313 nM). Meanwhile, the 14-mers (CaMKIIβ, CaMKIIδ and

CaMKIIδ) need less Ca2+/CaM. CaMKIIβ EC50 =21 nM, CaMKIIδ EC50 =167 nM and CaMKIIγ

EC50 =28 nM (Figure 4.12A). This is also correlated with their evolutionary divergence
(Sloutsky et al., 2020).
4.5

CaMKII chimeras stoichiometry support an allosteric role for the hub

regulating Ca2+ sensitivity for the CaMKII holoenzyme.
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Previously, CaMKII chimeras were used to support the allosteric effect of the CaMKII

hub on kinase activity (Sloutsky et al., 2020). CaMKII α kinase β hub showed an EC50 = 24

nM and CaMKII β kinase α hub showed an EC50 =102 nM. In section 4.4, it was shown that

CaMKII holoenzyme stoichiometry predicted Ca 2+ sensitivity. Therefore, the CaMKII

chimeras stoichiometry was also measured to analyze if this trend was also observed. First,
CaMKII α kinase β hub was measured at (660 kDa ± 64.4) and CaMKII β kinase α hub was
measured at (589.7 ± 82). This makes the CaMKII chimeras a 14- mer and 12-mer,

respectively (Figure 4.13). Thus, supporting a hypothesis where CaMKII holoenzyme

stoichiometry, apart from the CaMKII hub, may also allosterically regulate Ca2+ sensitivity.
4.6

Conclusions

The four human CaMKII hub domains are 90% identical (Sloutsky et al., 2020). Therefore, it

was expected that they should have similar if not identical oligomerization states in
solution. However, two stoichiometries were observed: 14-mer (CaMKIIα and CaMKIIγ) and
16-mer (CaMKIIβ and CaMKIIδ) (Fig. 4.2A) From these data, two observations were made.
First, the stoichiometries are related to the CaMKII hub evolutionary divergence. CaMKIIα

and CaMKIIγ are closely related, as well CaMKIIβ and CaMKIIδ. Therefore, it was interesting
to see that their stoichiometries were the same. Second, when looking at the population of

stoichiometries when acquiring the MP measurements for the hubs, CaMKIIβ and CaMKIIδ
hubs had fewer smaller species compared to CaMKIIα and CaMKIIγ hubs. In order to

understand this better, we measured their thermal stability with DSC. This led us to detect
that CaMKIIα (Tm = 90 °C) and CaMKIIδ(Tm = 82 °C) had lower melting temperatures.

CaMKIIβ and CaMKIIγ had higher melting temperatures of (Tm = 102 °C) and (Tm = 110 °C)
respectively. With this information, it was concluded that the lower the thermal stability,
dissociation occurs more readily. Lastly, the hub stoichiometries detected in solution were
different than the crystal structures stoichiometries previously reported (Rellos et al.,
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2010). Our CaMKIIβ hub crystal structure stoichiometries show a 14-mer and a 16-mer,

which the latter corresponds to our MP measurement. Further studies need to be done to
understand better what specifically causes these different stoichiometries.

In order to have a better understanding of how stoichiometry might affect kinase

activity, the stoichiometries of the CaMKII holoenzymes were investigated. Since the CaMKII

hub is the oligomerization domain, we expected their corresponding holoenzymes would
have similar stoichiometries. To our surprise, different patterns were observed. CaMKIIα

holoenzyme is a 12-mer and CaMKIIβ, CaMKIIγ and CaMKIIδ holoenzymes are 14-mers!

Excitingly, this correlated to the EC50 values because CaMKIIα shows an EC50 of 313 nM
while the bigger holoenzymes need significantly less. CaMKIIβ EC50 =21 nM, CaMKIIδ EC50

=167 nM and CaMKIIγ EC50 =28 nM. CaMKII chimeras stoichiometries were also measured,

and they showed a 12-mer for CaMKII β kinase α hub and a 14-mer for CaMKII α kinase β

hub. Their corresponding are EC50 =102 nM and EC50 = 24 nM. This supports that the hub,
when connected to a kinase, determines the stoichiometry of the CaMKII holoenzyme and
modulates Ca 2+ sensitivity.

Our study is the first one to characterize CaMKII hub and CaMKII holoenzymes

stoichiometry in solution. The correlation between Ca2+ sensitivity and stoichiometry of the
holoenzyme is clear and uncovers a new role for the hub. Additional studies need to be done

to inquire if this behavior might also be observed in cells. And if CaMKII holoenzyme
oligomer’s size might be another way how CaMKII regulates its activity in the different
cellular cascades involved in.
4.7 Methods

Molecular biology
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The WT CaMKIIα, CaMKIIβ, CaMKIIδ and CaMKIIγ holoenzymes with no

linker were cloned into a vector containing an N-terminal His-SUMO tag. The CaMKII

hubs were cloned from these constructs by inverse PCR to eliminate the kinases and
regulatory domain. The CaMKIIα hub was cloned into a pET-28 vector with an N-

terminal 6xHis-precission tag using Gibson assembly.
Protein purification

All four CaMKII holoenzymes were co-expressed with λ phosphatase using

Rosetta (DE-3)pLysS cells. The cells were induced at 18 °C with 1 mM Isopropyl βd-1-thiogalactopyranoside (IPTG) and grown overnight. The cells were then
suspended using Buffer A (25 mM Tris, pH 8.5, 150 mM KCl, 40 mM imidazole, 10%

glycerol), commercially available protease inhibitors (0.5 mM Benzamadine, 0.2 mM

AEBSF, 0.1 mg/mL trypsin inhibitor, 0.005 mM Leupeptin, 1 μg/mL aproptinin, 1
μg/mL pepstatin) plus 1 μg/mL DNAse. Purification was done at 4 °C using utilizing

a ÄKTA Pure system (GE). Clarified lysate was loaded onto a Ni-NTA column and
eluted with an imidazole gradient, desalted into Buffer C (25 mM Tris pH 8.8, 50
mM KCl, 40 mM imidazole, 2 mM TCEP, 10% glycerol) and cleaved overnight with

Ulp1 at 4 °C. Following a subtractive step, the sample was then bound to a HiTrap Q
FF column (GE) and eluded with a KCl gradient. Holoenzymes were purified using

a Superose 6 column (GE) into DSC buffer (25 mM Tris pH 8, 150 mM KCl, 1 mM

TCEP, and 10% glycerol). All purified holoenzymes eluted consistently (retention
volume12 mL).The pure protein was then frozen and stored at -80 °C.

The CaMKIIβ, CaMKIIγ ,CaMKIIδ hubs (335-475) were expressed separately

using BL21 cells and purified the same as the holoenzymes. The CaMKIIα hub
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domain (residues 315-475) was expressed in BL21 cells and purified as described

except a different Buffer C (25 mM Tris pH 8.8, 150 mM KCl, 1 mM EDTA, 2 mM DTT,

10 % glycerol) to facilitate Prescission protease cleavage overnight at 4 °C. Samples
were eluted from the Superose 6 column into DSC buffer. All purified hubs eluted
consistently (retention volume 14 mL). Pure protein samples were frozen and
stored at -80 °C.

Mass photometer measurements

All MP experiments were carried out using an OneMP mass photometer

(Refeyn LTD, Oxford, UK) at room temperature and used Acquire MP software for

data collection. Coverslips (cat #630-2105) were cleaned by rinsing with a series of
H2O, ethanol, and isopropanol (HPLC grade), and then dried under a clean stream of

nitrogen. Gaskets (catalog #CW-50R-1.0) were cleaned using H2O and ethanol, then
dried under nitrogen. The gasket was then sealed onto the center of the glass

coverslip. The coverslips were stored in a sterile container until used. 10 µl of buffer

(25 mM Tris, 150 mM KCl and 1 mM TCEP at pH 8.0) was added to the coverslip and
focused. Images were collected in an area of 3 x 10 µm at a frame rate of 1
kHz. Protein stock solutions (2 µM) were diluted to 200 nM (25 mM Tris, 150

mM KCl and 1 mM TCEP at pH 8.0) right before the experiment. Proteins diluted to
achieve the following concentrations in the measurements: 100 nM, 90 nM, 80 nM,

and 70 nM and 45 nM for all four hubs. And only 100 nM four holoenzymes. Three

replicates were performed at each concentration. Since the technical limit of the
instrument at low MW is 50 kDa, we will not be able to fully resolve monomeric hub
subunits (15.3 kDa) (Wu & Piszczek, 2020)
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Differential Scanning Calorimetry

All protein samples were diluted to 0.5 mg/mL in DSC buffer (25 mM Tris pH 8, 150

mM KCl, 1 mM TCEP, 10% glycerol). DSC measurements were performed on
a MicroCal Automated PEAQ-DSC instrument (Malvern Panalytical, Westborough,

MA). Unless otherwise indicated, after a 5 min pre-scan equilibration step, samples
were scanned from 10-120 °C at a scan rate of 90 °C/hr with no feedback. Data were

analyzed using MicroCal PEAQ-DSC software, and baseline-subtracted data were fit
to a non-two-state fitting model to obtain apparent Tm values.
CaMKIIβ hub crystal structure

In order to find suitable crystallization conditions, PEGrx HT (Catalog #: HR2-086,

Hampton Research) and Index HT (Catalog #: HR2-134, Hampton Research) screening trays

(3 Well Midi UVP, Catalog #: HR3-123, Hampton Research) were set up for β hub using a

Formulatrix brand NT8-Drop Setter. Crystallization for the screening trays was approached
using sitting drop vapor diffusion. The total drop size was 400 μL, consisting of 200 μL

reservoir solution and 200 μL protein sample at a concentration of 30 mg/mL. All crystals

were allowed to grow at room temperature (25 oC). These trays were then screened for hits

based on crystal size, shape, and quantity. Condition E12 on the PEGrx screening tray (0.15
M DL - malic acid pH 7.0, 22% PEG monomethyl ether 550, 0.1 M imidazole pH 7.0)

produced the best crystals and the most promising diffraction when shot at room

temperature. A 24 well crystal tray was then manually set up around this condition, so that

the concentration of DL-malic acid varied from 0.1 M to 0.2 M and the concentration of PEG

monomethyl ether 550 varied from 20% to 22%. Protein crystallization for the manual tray
(VDX Plate, Catalog #: HR3-140, Hampton Research)(22 mm Siliconized Glass Cover Slides,

Catalog #: HR3-233, Hampton Research) was approached via hanging drop vapor diffusion.
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Drops consisted of 1 μL reservoir solution and 1 μL protein at 30 mg/mL. Drops were
allowed to equilibrate over 500 μL of reservoir solution.

All crystals were grown at room temperature (25 oC). Crystals were observed using

a Volpi NCL-150 Fiber Optic Cold Light Source Illuminator after 24 hours. Crystals from the

C3 well (0.15 M DL - malic acid pH 7.0, 22% PEG monomethyl ether 550, 0.1 M imidazole pH
7.0) were shot under cryo-conditions using a Rigaku MicroMax-007 HF X-ray source, which

was coupled to a Rigaku VariMax HF optic system (UMass Amherst). No cryoprotectant

solutions were used, as PEG monomethyl ether 550 acts as a cryoprotectant at high enough
percentages (however some freezing was observed at 20% PEG monomethyl ether 550).

Several days after looping, the formation of crystals with different geometry was observed
in the same well. The aforementioned process was repeated for these crystals as well.
Data Collection and Analysis

Diffraction data were collected at a wavelength of 1.5418 Å using a Rigaku

MicroMax-007 HF X-ray source, which was coupled to a Rigaku VariMax HF optic system
(UMass Amherst). The X-ray data were collected at 100 K. Data sets were integrated,

merged, and scaled using HKL-2000. For data collection of the first crystal, 180 frames were

collected with a 4-minute exposure per frame. The space group was determined to be C2221

(a, b, c = 104.245, 183.204, 108.369; α, β, γ = 90.00, 90.00, 90.00) and the asymmetric unit
consisted of 7 monomers. For data collection of the second crystal, 180 frames were

collected with a 15-minute exposure per frame. Frames 105-145 were cut out due to poor

quality. The space group was determined to be P42212 (a,b,c = 81.790, 81.790, 180.184; α,

β, γ = 90.00, 90.00, 90.00) and the asymmetric unit consisted of 4 monomers. Molecular
placement for both cases was accomplished with Phaser using coordinates for the hub
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domain of CaMKIIγ (PDB identification code = 2UX0) as an initial search model. The

structures were built using the software Coot and refinement was performed with REFMAC.

MP Data Analysis

DiscoverMP software was used for all analyses using standard settings. Each

replicate was analyzed individually. Only molecules that bound to the glass surface
were

counted.

Populations

were

automatically

fit

with

a

Gaussian

distribution (Young et al., 2018). For these populations, the mean Gaussian values

from replicates were averaged to calculate an average MW, these values are
reported ± the standard deviation between three replicates.
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Figure 4.1 CaMKII protein domains and the four hub domains for the four CaMKII
genes. A) CaMKII subunit domain architecure B) CaMKII hub domains of all four genes.
CaMKIIα (blue), CaMKIIβ (pink), CaMKIIδ (green) and CaMKIIγ (purple).
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Figure 4.2 CaMKII hubs in solutions show different stoichiometry and different
patterns of dissociation at the same concentration (100 nM) with mass photometry.
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A) Mass photometry of all four CaMKII hubs: CaMKIIα (blue), CaMKIIβ (pink), CaMKIIδ

(green) and CaMKIIγ (purple). B) Small species/ big species plotted for all 4 hubs from 100
nM, 90 nM, 80 nM and 70 nM.

Figure 4.3. CaMKIIα hub dilution from 100 to 70 nM using mass photometry. Each

color: green, blue and yellow is a replicate. Therefore, each protein concentration was done
in triplicates.
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Figure 4.4. CaMKIIβ hub dilution from 100 to 70 nM using mass photometry. Each

color: green, blue and yellow is a replicate. Therefore, each protein concentration was done
in triplicates.
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Figure 4.5. CaMKIIδ hub dilution from 100 to 70 nM using mass photometry. Each

color: green, blue and yellow is a replicate. Therefore, each protein concentration was done
in triplicates.

72

Figure 4.6. CaMKIIγ hub dilution from 100 to 70 nM using mass photometry. Each

color: green, blue and yellow is a replicate. Therefore, each protein concentration was done

in triplicates.
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Figure 4.7 Differential Scanning Calorimetry for all four CaMKII hubs. Representative
traces are shown as well as the average apparent Tm rounded to the nearest integer

calculated from all replicates (replicates are in 4.8). A) CaMKIIβ (burgundy) and CaMKIIγ

hub (blue). B), CaMKIIα hub (blue) and CaMKIIδ (burgundy). C) All four CaMKII hubs.
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Figure 4.8 The replicates for DSC CaMKII hubs. The raw data and corresponding fits for

all DSC replicates are shown. Apparent Tm values are listed for all observed transitions. A)

CaMKIIβ hub, B) CaMKIIδ hub and C) CaMKIIγ hub.
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Figure 4.9 CaMKIIβ hubs crystal structure shows two different stoichiometries. A)

CaMKIIβ14-mer (light green). B) CaMKIIβ 16-mer (gray).
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Figure 4.10 CaMKII holoenzyme stoichiometries using mass photometry. CaMKIIα

holoenzyme (blue), CaMKIIβ (dark pink), CaMKIIδ (aqua) and CaMKIIγ (purple). Each color:

green, blue and yellow is a replicate. Therefore, each protein concentration was done in
triplicates.
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Figure 4.11 CaMKII holoenzymes stoichiometries using mass photometry replicates.
CaMKIIα holoenzyme (blue), CaMKIIβ (dark pink), CaMKIIδ (aqua) and CaMKIIγ (purple).

Each color: green, blue and yellow is a replicate. Therefore, each protein concentration was
done in triplicates.
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Figure 4.12 CaMKII holoenzymes and CaMKII chimeras stoichiometries using mass
photometry are related to calcium sensitivity. A) CaMKII holoenzymes with their

calculated oligomer size using mass photometry and their corresponding EC50 value from

(Sloutsky et al., 2020). CaMKIIα holoenzyme (blue), CaMKIIβ (dark pink), CaMKIIδ (aqua)
and CaMKIIγ (purple). B) CaMKII chimeras: CaMKII α kinase β hub (blue kinase, purple

hub) and CaMKIIβ kinase α hub (purple kinase, blue hub) with their calculated oligomer

size using mass photometry and their corresponding EC50 value from (Sloutsky et al., 2020).
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Figure 4.13 CaMKII chimeras stoichiometries using mass photometry and replicates
A) CaMKII chimeras: CaMKII α kinase β hub (blue kinase, purple hub) and CaMKII β kinase α
hub (purple kinase, blue hub) B) Each color: green, blue and yellow is a replicate. Therefore,
each protein concentration was done in triplicates.
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CHAPTER 5
LIVE-CELL FLIM-FRET USING A COMMERCIALLY AVAILABLE SYSTEM
As written by Castellani Colleen M, Torres-Ocampo Ana P.,Breffke Jens, White Adam B.,

Chambers James J., Stratton Margaret M. and Maresca Thomas J. Published in Methods
in Cell Biology in March 2020

I imaged Camui FRET biosensor in HEK cells and wrote part 5.6. I also helped with the edits
for the final manuscript.

5.1

Abstract
Förster resonance energy transfer (FRET)-based sensors have been powerful tools

in cell biologists’ toolkit for decades. Informed by fundamental understanding of fluorescent
proteins, protein-protein interactions, and the structural biology of reporter components,

researchers have been able to employ creative design approaches to build sensors that are
uniquely capable of probing a wide range of phenomena in living cells including

visualization of localized calcium signaling, sub-cellular activity gradients, and tension

generation to name but a few. While FRET sensors have significantly impacted many fields,
one must also be cognizant of the limitations to conventional, intensity-based FRET

measurements stemming from variation in probe concentration, sensitivity to
photobleaching, and bleed-through between the FRET fluorophores. Fluorescence lifetime
imaging microscopy (FLIM) largely overcomes the limitations of intensity-based FRET
measurements. In general terms, FLIM measures the time, which for the reporters

described in this chapter is nanoseconds (ns), between photon absorption and emission by
a fluorophore. When FLIM is applied to FRET sensors (FLIM-FRET), measurement of the

donor fluorophore lifetime provides valuable information such as FRET efficiency and the
percentage of reporters engaged in FRET. This chapter introduces fundamental principles of
FLIM-FRET toward informing the practical application of the technique and, using two
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established FRET reporters as proofs of concept, outlines how to use a commercially
available FLIM system.
5.2

Introduction

For years the application of fluorescence lifetime imaging microscopy (FLIM)

techniques has largely been the purview of specialists; the objective of this methods chapter

is to make FLIM-FRET accessible to generalists—specifically cell biologists who are already

familiar with live-cell fluorescence microscopy approaches. Many FLIM systems in use
today are custom-built and housed in labs with expertise in developing and maintaining

advanced microscope systems. The microscope described in this chapter is a commercially
available “turn-key” system that is stable enough to be housed in a microscopy core facility.
For most, the core facility will be the best economic model for incorporating FLIM-FRET
into their research program as the hardware requirements include a laser scanning confocal

microscope, high-frequency pulsed lasers, and time-correlated single photon counting
(TCSPC) detectors. The protocol will also include standard operating procedures for
acquiring and analyzing FLIM-FRET data using well-established software from Nikon (NISElements) and Becker & Hickl.

FLIM measures how long a fluorophore is in its excited state to determine its

fluorescent lifetime (Elangovan et al., 2002) There are two major modalities of acquiring
FLIM data referred to generally as “frequency domain” FLIM and “time domain” FLIM. This

chapter will deal exclusively with time domain FLIM using time-correlated single photon
counting (TCSPC). TCSPC uses a pulsed laser with one or more single photon detectors.
Photons are sorted based on arrival time to the detector in relation to the excitation signal.

A decay curve is constructed by plotting the time of photon arrivals following an excitation
pulse versus intensity, which is the number of photons detected at a given arrival time (Fig.
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5.1). The lifetime of a fluorophore (τ) is defined as the arrival time where the population of

photons has decayed to 1/e of the original population or intensity. Using TCSPC with a
scanning confocal head, high spatial resolution can be attained, but depending on the lasers,

detectors, and reporter brightness, long acquisition times (minutes) may be required to

attain a sufficient number of photons for robust data analysis (Padilla-Parra et al., 2008).

This methods chapter will begin by outlining basic principles of FRET and FLIM before

shifting focus to practical considerations such as hardware requirements (with associated
cost estimates) and appropriate donor selection for FLIM-FRET sensors. A step-by-step

protocol for acquiring FLIM images on a Nikon scanning confocal system using NISElements in sync with SPCM64 (Becker & Hickl) will be detailed using the real world
example of a previously characterized FRET biosensor.

Step-by-step protocols are presented for conducting FLIM analyses in SPCImage (Becker &
Hickl) to determine: (1) the donor lifetimes in the presence and absence of FRET, (2) the
percentage of reporter engaged in FRET in your sample, and (3) FRET efficiency. The

principles of the Phasor Plot—an approach for displaying and analyzing FLIM images will
be introduced and a protocol for Phasor Plot analysis in SPCImage is presented. A second

proof-of-concept example of FLIM-FRET using the system described here is presented
followed by the introduction of a FLIM-FRET acquisition and analysis platform that will

soon be released by Nikon to interface with their NIS-Elements software. In summary, this

chapter describes how to visualize and analyze FRET sensors using a commercially
available FLIM system that has proven robust enough to become a workhorse microscope in
a core facility.
5.3

Principles of FLIM-FRET
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FRET is a non-radiative energy transfer from one fluorophore in the excited state

(the donor) to another molecule in the ground state (the acceptor), which is typically
located less than 10 nm away. In order for FRET to occur three conditions must be fulfilled:

(1) The donor emission spectrum must overlap with the absorption spectrum of the
acceptor

(2) Both molecules must be within angstroms to nanometers distance to each other
(3) Both molecules must have a matching dipolar orientation

Since the energy transfer efficiency changes as the inverse sixth power (r-6) of the distance r
between the donor and acceptor, selection of the proper FRET pairs allows the researcher

to monitor distance changes in the angstrom and nanometer range, which makes the
approach relevant for probing macromolecular structural dynamics at the scale of proteins

and nucleic acids within living samples. A common measurement technique is intensity-

based FRET, which can be performed with confocal or wide field microscopy approaches.
Intensity-based FRET can be measured either through the donor (acceptor-photo
bleaching) or the acceptor (sensitized emission). Unfortunately, both techniques generate

experimental challenges due to spectral cross-talk, photo bleaching sensitivity, and variable

reporter concentration.

A better way to determine FRET efficiencies has been the use of measuring the

fluorescence lifetime of the donor. The lifetime is the half time a molecule spends in the first

excited state and is on the nanosecond time scale (10-9 seconds) for common FRET donors.
In a FRET experiment a fluorescent molecule (the donor) in the excited state can return to
the ground state either by emitting a photon (fluorescence) or in a non-radiative way by
transferring energy to the acceptor, as discussed above. This transfer is associated with a

probability over time meaning the longer the donor is in the excited state the higher the
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likelihood it will engage in FRET. Since there are two competing kinetic pathways
(fluorescence and non-radiative) under FRET conditions, the lifetime of the donor becomes

shorter than its lifetime under non-FRET conditions. The lifetime (τ) can be described and
mathematically fitted using an exponential function or a sum thereof of the fluorescence
intensity as a function of time:

𝐼𝐼 (𝑡𝑡) = � 𝑎𝑎𝑎𝑎𝑎𝑎 − 𝑡𝑡/ 𝜏𝜏i

Where ∑ 𝑖𝑖𝑖𝑖𝑖𝑖 = 1

An ideal FRET donor should exhibit a single exponential decay (further details

below). When engaged in FRET, the single exponential decay curve now exhibits a doubleexponential behavior (Fig. 5.2). Since some fraction a1 of donors will not have acceptor in
their vicinity, these donors would fluoresce with the normal baseline lifetime τ1. However,

a fraction of donor a2 will be undergoing FRET, which introduces a second lifetime
component τ2 that is shorter (or faster) than the native donor. The result is an average

fluorescence lifetime (τFRET) where:

τFRET = a1 τ1 + a2 τ2

For the FLIM-FRET approaches outlined in this chapter you will need two measurements:

(1) cells with only the donor expressed to determine the lifetime (τ) of the donor in your

model system and (2) cells expressing the FRET reporter that includes both the donor and
the acceptor in the same sample system. Once the baseline lifetime of the donor under non-

FRET conditions in your cell line is known (τD) and the lifetime of the donor under possible

FRET conditions (in the presence of an acceptor) has been measured (τFRET), the FRET

efficiency (E) can also be calculated by:
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𝐸𝐸 = �1 −

τFRET
� 𝑥𝑥 100 %
τD

Unlike intensity-based FRET experiments, the acceptor can be “dark” or

nonfluorescent (Ganesan et al., 2006; Murakoshi et al., 2008, 2015) because only the
lifetime of the donor needs to be measured. In addition, you can measure each experiment

independent of excitation intensity and integration time as long as your data has sufficient
signal-to-noise to reveal its decay characteristics. Consequently, when FLIM is applied to

FRET sensors (FLIM-FRET), measurement of only the donor fluorophore lifetime, which

negates bleed-through concerns, provides valuable information such as FRET efficiency and
the percentage of reporter engaged in FRET in a manner that is independent of local probe
concentration and less sensitive to photo bleaching than conventional FRET measurements.
5.4

Equipment and materials

A FLIM system can be set up on an existing scanning confocal microscope system

such as the Nikon A1 confocal system described here, which is depicted in Fig. 5.3. In the

method outlined in this chapter the system was set up to visualize the FRET donor
mTurquoise2 (CFP variant) and FRET acceptor mVenus (YFP variant) although other FRET
pairs can be used with the appropriate pulsed lasers, filters, and dichroic mirrors. A parts

list and estimated costs for a system with four pulsed lasers (405, 445, 488, and 561 nm),

accompanying filters and dichroic mirrors, and two TCSPC detectors is provided in Table 1.
A system need not require this number of laser lines (plus appropriate filters and dichroic

mirrors) and detectors and could function with as little as a single pulsed laser for your
FRET donor of choice and a single detector to count the emitted photons. It is also
important to note that the addition of FLIM capabilities does not negatively impact the
other imaging modalities on the microscope to which it is added.
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Live cell imaging

1. Scanning confocal microscopy equipment - Images and FLIM data were acquired

on a Nikon Ti-E microscope body that was fitted with an A1 confocal scan head. The scan

head has two laser input ports and three emission output ports. Four continuous-wave
lasers (Nikon LUN-V; 405,488, 561, and 640 nm) were combined and fiber-coupled into one

input port and four pulsed lasers (Becker & Hickl; BDL-405-SMN, BDL-445-SMN, BDL-488-

SMN, and BDS-561-SMY; 405, 445, 488, and 561 nm, respectively) were combined and
fiber-coupled into the second input port. The first output port of the scan head was

connected to the Nikon A1-DU4G that contains five PMT detectors, the second port

connected to the Nikon 32-channel spectral detector A1-DUs, and the third port connected
to a pair of Becker & Hickl HPM-100-40 detectors.

2. Time-correlated single photon counting (TCSPC) detectors - Two Becker & Hickl HPM-10040 detectors were coupled to a changeable filter cube that consisted of an appropriate
dichroic mirror and two band pass emission filters; for CFP/YFP 488/50BP, 520LP,
550/49BP (Semrock, FF01-488/50, FF520-Di02, FF01-550/49, respectively).

3. Final comments on approaches to live-cell imaging - Once cell lines expressing the FRET

reporters have been made, sufficient time should be spent at the microscope familiarizing

oneself with the cells prior to doing FLIM-FRET experiments. If it is difficult to readily
assess the extent of chromosome alignment by phase contract or DIC microscopy, as is the
case for Drosophila S2 cells, then “scanning” for cells will require the use of epifluorescence
and; therefore, limiting photo bleaching of the reporters is critical. If CFP-YFP variants are

used as your FRET pairing (as is the case in this protocol) then co-transfecting the cells with
an RFP-tagged construct such as mCherry-α-tubulin will aid in this process as you can scan

on the RFP channel to avoid photobleaching of the donor or acceptor. If you will be scanning
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cells with epifluorescence then aim for a level of proficiency in which the necessary cellular
states (e.g., mitotic versus interphase) can be identified and centered in the field of view
within ~3–5 seconds.

5.5 Proof of concept 1 – CyclinB1-Cdk1 activity reporter in Drosophila S2 cells
The first proof of concept will make use of a previously characterized reporter for

CyclinB1- Cdk1 kinase activity (Gavet & Pines, 2010) in which the donor (mCerulean) has

been replaced with mTurquoise2 (Goedhart et al., 2012), which exhibits a monoexponential decay, and the acceptor (YPet) has been replaced with mVenus. The FRET pairs

flank the autophosphorylation site of human CyclinB1, which is a substrate of active
CylinB1-Cdk1, and a phospho-binding domain comprised of the Polo Box Domain (PBD) of

Polo-like kinase 1 (Plk1). Consequently, the sensor undergoes a conformational change
when it is phosphorylated by Cdk1 that results in an increase in intramolecular FRET

(Figure 5.4). Prior work demonstrated that this reporter specifically reports on CyclinB1-

Cdk1 activity and exhibits increased FRET in mitosis and decreased FRET in interphase. In
the case of the CyclinB1-Cdk1 reporter used in this proof of principle, a nonphosphorylatable control was also used to confirm that any measured changes in donor

lifetime and FRET efficiency were indeed due to its phosphorylation rather than non-

specific changes in its conformation between interphase and mitosis. It is also important
that the lifetime of the donor in the absence of an acceptor (no FRET condition) be

measured in the cell line of interest to accurately analyze FLIM-FRET data under possible
FRET conditions. The Cdk1 activity reporter, control non-phosphorylatable reporter, and

mTurquoise2 (donor alone) were cloned into the Drosophila cell expression vector pMT-V5HisB (Thermo Fisher) in which their expression was under the control of a promoter

sequence that drives constitutive, but moderate levels of expression. The chapter will not
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detail the transfection protocol or general culturing of Drosophila S2 cells as we have
detailed this elsewhere (Ye & Maresca, 2016).

A.

Measuring donor lifetime

Ideally, the donors used for FLIM should exhibit single exponential decay (Martin et

al., 2018). Unfortunately, this property excludes many commonly used fluorophores. Since

analysis of donors that exhibit multi-exponential decay is technically challenging and not as

clean or reliable as the analysis of mono-exponential decay data we strongly encourage

researchers to invest time up front in engineering their FRET sensors to contain an
appropriate mono-exponential donor. There are now multiple fluorophore options that are
well-suited for use with FLIM-FRET since newly innovated fluorophores are increasingly

becoming available (Goedhart et al., 2010). These include the modification of multi-

exponential decay fluorophores to exhibit single exponential decay (Goedhart et al., 2010)

as well as modifications of single exponential decay fluorophores to increase their
fluorescence intensity and/or increase fluorescence lifetime (Goedhart et al., 2010; Kremers

et al., 2006; Markwardt et al., 2011). Table II shows fluorophores that exhibit single
exponential decay, and thus are best suited for use with FLIM-FRET. The reporters

highlighted in this chapter as proof of principles all involve intramolecular FRET using
mTurquoise2 as the donor and mVenus as the acceptor and the protocols/hardware are

outlined as such. If you are not using a CFP/YFP pairing then pulsed lasers, filters, and
dichroic mirrors should be changed accordingly to match your FRET pair of choice.
1. Establishing donor fluorophore lifetime in the absence an acceptor/FRET
a. Procedure

90

1.

Seed Drosophila S2 cells expressing the donor (mTurquoise2) on a concanavalin A

coated glass bottom 35 mm dish (Cellvis, Part No. D35-20-1.5-N) at ~70% confluency. After

the cells adhere (~30 minutes), bring the volume up to 2 mls using fresh Schneider’s media

supplemented with 10% heat inactivated FBS (Life Technologies). Allow the cells to flatten
for an additional 30 minutes.

2. Once mounted on the microscope, quickly scan by eye under widefield fluorescence

settings on the GFP channel (or the RFP channel if co- transfected with an RFP-tagged
construct) and center cells of interest in the field of view.

3. Setup the confocal imaging parameters in the A1Plus Compact GUI. In our system the
settings were set to image size 512×512 with a pixel dwell time set to 2.2 μs/pixel and a

pinhole size set to 1.0 airy units (AU), which is based on the excitation wavelength and is
automatically defined in the GUI. Note: these settings matched the FLIM acquisition

parameters allowing a direct comparison of the fields between the confocal image and the
FLIM image.

4. In the A1Plus Compact GUI, click on “Scan” to obtain the best focal plane of your cell of

interest. If you expect to present confocal images alongside your FLIM images then define

parameters such as laser power and gain, avoiding pixel saturation, to acquire a quality confocal
image of your sample. Save the image to the appropriate folder.
5. In the A1plus Compact GUI click on “AUX”. This changes the output from the scan head so
that emitted photons will be sent to the TCSPC detectors.
6. In the A1plus Settings GUI in the “Filter and Dye” tab click on “AUX”. The “AUX Settings”
GUI will appear to allow you to define the system settings such that the input into the scan head
will be the pulsed laser and the proper dichroic mirror will be positioned in the light path to allow
the appropriate emitted photons to reach the TCSPC detectors. On our system, under “Filter and
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Dye” 400–457/514 was selected in the dropdown next to “1st DM” and the laser was set to “Port
2” in the dropdown under “Detector External”., All boxes under “Acquisition” in the AUX
Settings GUI were unchecked.
7. Click on “START” at the top of the AUX SETTINGS interface. You will hear the scan head
turn on although no laser light will be hitting the sample yet. At this point, be sure that the
appropriate pulsed laser (ours was 445 nm set to 50 mHz) is turned on.
8. Open SPCM64 and load settings from a template file supplied by the system installer or, if a
return user, by loading a file from a prior experiment. To load a file, select the “MAIN” tab at the
top of the window and click on “LOAD” in the dropdown. In the “SPC-150 Load SPC-file” popup window select “file name” to open a file from a destination folder. After selecting the file
name be sure to complete the action by clicking on “LOAD (F10)”. Once completed, the
appropriate hardware settings will be loaded and appear in the “M1/M2 DCC-100” pop-up
window.
9. Configuration settings will vary depending on the hardware you have and its installment. In the
hardware configuration for our system, Module 1 controls the TCSPC detectors and a shutter that
allows light into the detectors, Module 2 controls the 405 and 445 nm pulsed lasers, and Module
3 controls the 488 and 561 nm pulsed lasers. Thus the configuration was as follows:
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10. To begin acquiring an image toggle to Module 1 in the lower left hand corner of M2 DCC100 pop-up window to control the two detectors (Connectors 1 and 3 – with the +12V, +5V, and
−5V boxes highlighted and “Gain /HV set to 84.00) and the shutter (Connector 2 – only “b0”
highlighted). Click on “Enable outputs” to provide power to the detectors and shutter in module
1. After doing this step you will see baseline signal in the detectors in the lower left of the
SPCM64 screen above columns labeled “CFD” and “TAC”.
11. Since the 445 nm laser is being used, toggle to Module 2 in the pop-up window. The interface
will now allow you to power the appropriate laser and set its power. To do so highlight +5v under
Connector 3 (445 nm pulsed laser) and adjust laser to desired power. For our experiments, we
found that up to 50% laser power worked well. Click on “Enable Outputs” to provide power to
the laser. After doing this step you will see laser light through the objective and increased signal
will be evident in the lower left of the SPCM64 screen above all four columns labeled “SYNC”,
“CFD”, “TAC”, and “ADC”.
12. Click on the “Start!” tab at the top of the window to acquire data. Images of the FRET donor
and acceptor will appear in two separate windows. In our system, the “W1-FLIM1” window on
the left shows the mVenus image while the “W2-FLIM2” window on the right shows the
mTurquoise2 image – both of which will appear brighter over time as more photons are collected.
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Aim to acquire 30–50 million photons per scan, which will be tallied (as well as the elapsed time)
in a blue highlighted window in SPCImage next to “Collecting data”.
13. Once enough photons have been collected click on the “Stop!” tab at the top of the window to
stop acquiring photons.
14. In the M1/M2 DCC-100 pop-up window click on “Disable all modules” to turn off the
detectors, shutter, and pulsed laser.
15. Save the data by selecting the MAIN tab and clicking on “SAVE” in the drop down. In the
“SPC-150 Save SPC file” pop-up click on “Select File (F9)” and select or create a file folder in
which to save the FLIM images and to name the file. After selecting the destination folder and
creating the file name, which should have a similar naming convention as the confocal image file
saved in step 4, be sure to complete the saving action by clicking on “Save (F10)”.
16.

Return to NIS-Elements and click on “STOP” in the AUX SETTINGS GUI and then

click on “Close” at the bottom of the AUX SETTINGS window. This will close the window and
allow you to search for new cells to image.
17.

Repeat steps 2–16 for as long as your sample is viable or the duration of your microscope

time – whichever comes first.
b. Donor lifetime measurements using SPCImage in donor alone conditions
1. Open your FLIM data in the SPCImage software by selecting the “File” tab at the top of the
SPCImage window and clicking on “Import”. In the “Open” pop-up window select your file of
interest and click on “Open”.
2. A pop-up window entitled “Options for YOUR FILE NAME.sdt” will appear. Under “Select
data” in the lower right hand corner of the pop- up, identify the “Module Number” to open the
data from the detector used to collect photons from the donor. Since our data was collected on
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detector 2, we selected Module Number “2” for both column options. After clicking “OK” in the
pop-up window, the FLIM data will appear in the left window in SPCImage (Figure 5.5).
3.

In the “Multiexpontial Decay” interface (bottom of screen, right of the decay curve)

select “1” for “Components”. None of the values in the Multiexpontial Decay interface should be
fixed except “Scatter”, which should be fixed at “0” by checking the “Fix” box. (Figure 5.5 –
Inset 1).
4.

Select the “Options” tab at the top of the SPCImage window and click on “Color” in the

drop-down. In the pop-up window entitled “Color”, click on “Continuous” and set the appropriate
lifetime “Range” to encompass the expected lifetime ranges – for the mTurquoise2 donor this was
set from 600 (ps) to 3800 (ps). The lifetimes will be displayed in a color scale depending on
whether the “Direction” is set to “R-G-B” or “B-G-R”. For example, if “R-G-B” is selected then
the longest lifetimes (3800 ps) will be displayed as blue and the shortest lifetimes (600 ps) will be
displayed as red, which would be inversed if “B-G-R” is selected. Since longer average lifetimes
indicate lower FRET and shorter average lifetimes indicate higher FRET, we chose to display as
R-G-B. Under “Coding of” at the bottom of the pop-up select “tm (ps)” in the dropdown for the
“Value”. Click on “OK”.
5. Blue crosshairs will automatically center upon the brightest pixel when you import an image.
Move the cursor to the dimmest area of the cell you wish to analyze. In the decay curve window
below the image, adjust the binning such that the peak intensity of the decay function (bottom of
screen, below FLIM image window) is at least 100 A.U. (y- axis) (Figure 5.5 – Inset 2).
6. At this point, if you plan on analyzing multiple images using the same analysis parameters then
it is helpful to “Store the fit conditions” by clicking on the camera icon in the tab to the left of the
FLIM image window (Figure 5.5 – Inset 3).
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7. Select the “Calculate” tab at the top of the SPCImage window and click on “Decay Matrix” in
the drop-down, which will generate a color-coded FLIM lifetime image in the right window in
SPCImage.
8. The blue crosshairs can be positioned in either image window to assess local lifetimes. When
the crosshairs are moved the lifetime value displayed above the decay curve as “tm = X ps”
(Figure 5.5 – Inset 4) will change. The values in the “Multiexponential Decay” interface will also
change. In the case of the mono-exponential fit being done in this section, the t1[ps] value will
match the lifetime value above the decay curve and the a1[%] will read “100”.
9. The pixels encompassing a region of interest (ROI) can be grouped together to measure the
lifetime parameters for an entire cell or region of a cell. The “τm (shown above the decay
curve) is generated by binning all the pixels in the ROI. To define an ROI, click on the “Define

mask (move red crosshair)” icon in the tab to the left of the FLIM image (Figure 5.5 – Inset

5). Red crosshairs will appear in the FLIM image windows. Left click on the red crosshair to
position it where you want to draw the ROI and then alternate between left clicking and
moving the cross hair around your cell of interest in the left image window to draw the ROI.

10.Once the ROI is drawn, “Activate binning of all pixels inside mask” by clicking on the red
lock icon in the left tab (Figure 5.5 – Inset 6). Once the mask is locked, the blue crosshairs will
disappear and the ROI will become bold. At this point, all the lifetime value parameters will be
for the area within the ROI.
11.When you are ready to generate a new ROI, “Deactivate binning of all pixels inside mask” by
clicking on the red unlocked lock icon in the left tab (Figure 5.5 – Inset 7). The ROI will no
longer be in bold and the blue crosshairs will reappear. Click on “Undefine the mask” in the left
tab (Figure 5.5 – Inset 8) and the ROI will disappear.
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12.Repeat steps 9 – 11 on all the cells or regions of cells you would like to analyze in a given
image. Import a new file once you are done analyzing an image. If you are sequentially analyzing
the same experimental conditions then “Load fit conditions” (Figure 5.5 – Inset 9) by clicking on
the yellow arrow in the left tab – confirm parameters in the “Multiexponential Decay” interface
are appropriate and repeat steps 7 – 12 as needed.
13. We analyzed and averaged data from 50 cells expressing mTurquoise2 to attain the lifetime
(τD) of 3.57 ns +/− 0.07 ns (mean +/− S.D.) in Drosophila S2 cells. The value of 3573.2 ps

(note SPCM64 software deals in ps rather than ns) was used for all future analyses
(described below) to fit a double-exponential decay function under possible FRET
conditions in which the acceptor mVenus was present.

14. Protocol note: FLIM analysis can be done on a smaller region of the field of view by
dragging in the white crosshairs from the corners of the donor image in the left window. To

“Zoom In” on a highlighted region, which will be outlined by white lines, click on the “+”

magnifying glass icon in the left tab (Figure 5.5 – Inset 10). Zooming in will speed up the

calculation of the decay matrix. You can “Zoom Out” to the original field of view by clicking
on the “-” magnifying glass icon in the left tab (Figure 5.5 – Inset 11).

2. Measuring donor lifetime and FRET efficiency in the presence of an acceptor
a. Procedure

1. Repeat the procedure from the “Establishing donor fluorophore lifetime in the absence an

acceptor/FRET” on cells expressing the FRET reporter in which both the donor
(mTurquoise2) and acceptor (mVenus) are present.
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b. Donor lifetime measurements via double exponential fitting of FLIM-FRET data using
SPCImage
1. Repeat steps 1 and 2 from Donor lifetime measurements using SPCImage in donor alone

conditions

2. In the “Multiexpontial Decay” interface (bottom of screen, right of the decay curve) select

“2” for “Components”. Fix the long (no FRET) donor lifetime for t2[ps] by entering the
lifetime measured for the donor alone in your sample of interest and checking on the “Fix”

box. In our case the t2 [ps] was fixed at “3573.2” (measured above). Fix the “Scatter” at “0”.
No other parameters should be fixed.

3. Repeat steps 4 – 7 from Donor lifetime measurements using SPCImage in donor alone
conditions
4.

The blue crosshairs can be positioned in either image window to assess local

lifetimes. When the crosshairs are moved the lifetime value displayed above the decay curve

as “tm = X ps” will change. This value is the lifetime calculated from the double exponential fit
values shown in the “Multiexponential Decay” interface. In the case of the 2- exponential fit

being done in this section, the interface will display the percentage of the reporter engaged in
FRET as a1[%], the short lifetime of the donor (due to FRET) as t1[ps], and the percentage of
reporter not engaged in FRET as a2[%]. The long lifetime t2[ps] will read the value at which it
was fixed (for us this was 3573.2).
5.

Repeat steps 9 – 12 from Donor lifetime measurements using SPCImage in donor alone

conditions as necessary to acquire a sufficient amount of data for your needs. FLIM-FRET
lifetime measurements for the cylinB1-Cdk1 reporters in this proof of principle are reported in
Table III.
c.

Measuring FRET efficiency from FLIM-FRET data using SPCImge
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FRET efficiency can be calculated given the fluorescent lifetime of the donor fluorophore under
both FRET and non-FRET conditions. The equation:
𝐸𝐸 = �1 −

τFRET
� 𝑥𝑥 100 %
τD

calculates FRET efficiency (E), where τ𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 is the lifetime of the donor under FRET

conditions, and τD is the lifetime of the donor under non-FRET conditions (measured

above). FRET efficiency can be calculated manually by recording the average lifetime of

your ROI (displayed as “tm = X ps” above the decay curve) and plugging this value into the
equation above for that you have measured. FRET efficiencies calculated from the values

measured using the protocols described above for the cylinB1-Cdk1 reporters in this proof
of principle are reported in Table IV. SPCImage also has a useful function to display the

decay matrix as a function of FRET efficiency using the long lifetime that you enter into the
software in the double-exponential fitting interface. The following protocol discusses how

to use SPCImage to convert lifetime data to FRET efficiency for visual representations.

1. Repeat steps 1 and 2 from Donor lifetime measurements using SPCImage in donor alone
conditions

2. In the “Multiexpontial Decay” interface (bottom of screen, right of the decay curve) select “2”
for “Components”. Fix the long (no FRET) donor lifetime for t2[ps] by entering the lifetime
measured for the donor alone in your sample of interest and checking on the “Fix” box. In our
case the t2 [ps] was fixed at “3573.2” (measured above). Fix the “Scatter” at “0”. No other
parameters should be fixed.

3. Select the “Options” tab at the top of the SPCImage window and click on “Color” in the

drop-down. In the pop-up window entitled “Color”, click on “Continuous” and set the appropriate
lifetime “Range” to encompass the expected FRET efficiency range – for the CyclinB1-Cdk1
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reporter this was set from 0 (%) to 55 (%). The FRET efficiencies will be displayed in a color

scale depending on whether the “Direction” is set to “R-G-B” or “B-G-R”. For example, if “RG-B” is selected then the highest FRET efficiency (55%) will be displayed as blue and the
lowest FRET efficiency (0 %) will be displayed as red, which would be inversed if “B-G-R” is

selected. We chose to display the FRET efficiencies as B-G-R as this is the convention for
displaying FRET data. Under “Coding of” at the bottom of the pop-up select “1 –

dropdown for the “Value”. Click on “OK”.

τm
“
τ2

in the

4. Blue crosshairs will automatically center upon the brightest pixel when you import an image.
Move the cursor to the dimmest area of the cell you wish to analyze. In the decay curve window
below the image, adjust the binning such that the peak intensity of the decay function (bottom of
screen, below FLIM image window) is at least 100 A.U. (y-axis) (Figure 5.5 – Inset 2).
5. At this point, if you plan on analyzing multiple images using the same analysis parameters then
it is helpful to “Store the fit conditions” by clicking on the camera icon in the tab to the left of the
FLIM image window (Figure 5.5 – Inset 3).
6. Select the “Calculate” tab at the top of the SPCImage window and click on “Decay Matrix” in
the drop-down, which will generate a color-coded image in the right window in SPCImage
displaying FRET efficiencies with the lowest FRET in blue and the highest FRET in red.
7. The FRET efficiencies can be analyzed with ROIs by repeating steps 9 – 12 from Donor
lifetime measurements using SPCImage in donor alone conditions; however, the value reported
above the decay curve will now display the FRET efficiency of the binned pixels in the ROI
rather than lifetime.
B. Phasor plots
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The Phasor plot originates from measuring lifetime in the frequency domain and was developed
by Enrico Gratton (Digman et al., 2008). In such, the lifetime data is illustrated in a polar system
in which the data is presented in a semicircle. The vector pointer (also called “phasor”) from the
left hand coordinate origin is drawn with the phase as its angle and the amplitude as its length
(Figure 5.6). The lifetime is plotted based on these two numbers independent of the pixel location
within the image. The advantages are:
1. The phasors of pixels with single-exponential decay profiles are located along the
semicircle
2. Phasors of multiple decay components are linear combinations of the phasors of the
components and will end up inside the semicircle
3. Pixels with similar phase and amplitude values form visible clusters. Therefore, pixels
with similar lifetime signatures can be identified in the phasor plot.
4.

Lifetime clusters in the dataset can be back annotated and identified in the image display
using a selection tool (Figure 5.7).

Taking the time-domain lifetime data you get from TCSPC measurements we can obtain the
phase and amplitude values by its first Fourier components.
Phasor plot analysis to determine spatial distribution of fluorescent lifetimes in SPCImage
1. Repeat steps 1–3 from Donor lifetime measurements via double exponential fitting of
FLIM-FRET data using SPCImage

2. Select the “Tools” tab at the top of the SPCImage window and click on “Phasor Plot” in the
drop-down.

3. In the “Phasor Plot” GUI that opens set the “Repetition Time (Laser):” to 20.0 ns and

check on the box next to “Combine with FLIM analysis.” Click on the “Recalculate” button,

101

which will be blinking in red and read “Please Recalculate”. A pixel distribution will now
appear within the phasor plot. Pixels on the semicircle are exhibiting mono-exponential

decay and their position on the semicircle will indicate their lifetime, which is labeled in
“ns” along the semicircle. Pixels inside the semicircle indicate that they are best fit with
higher multi-exponential decay functions. In the case of FRET, these pixels should fit a
double-exponential decay function.

4. The crosshairs can be dragged and resized with the mouse to highlight clusters of pixels
that are apparent in the phasor plot (Figure 5.7B, C). To selectively view pixels in the ROI

from the phasor plot in the FLIM image, click on the “Select cluster” box. Pixels exhibiting

the lifetime within the selected circle will be displayed in the FLIM image while pixels not

exhibiting the lifetime within the selected circle will be displayed in the grayscale image on
the left. The image displays will be update when you move and/or resize the ROI in the
phasor plot.

5.Another useful feature of the phasor plot analysis interface is that when you move the

blue crosshair in the donor/FLIM image windows, a corresponding blue crosshair will be

positioned in the phasor plot so that you see if the FLIM ROI falls into a cluster in the phasor
plot.

5.6 Proof of concept – Camui CaMKII sensor in human HEK293T cells
Ca2+-calmodulin dependent protein kinase II (CaMKII) is a Ser/Thr kinase that plays crucial

roles in memory formation, cardiac signaling, and fertilization (H. Y. Chang et al., 2009;

Eisner et al., 2017; Herring & Nicoll, 2016b) As suggested by its name, CaMKII is turned on
by a Ca2+ elevation, leading to Ca2+ loaded calmodulin (Ca2+-CaM), which ultimately leads to

the relief of autoinhibition in CaMKII (M. M. Stratton et al., 2013). Camui is a FRET biosensor
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for CaMKII activity (Takao et al., 2005). When CaMKII binds Ca2+-CaM, it undergoes

significant conformational change, which is reported in Camui by placing a FRET pair at the
N- and C-termini (Fig. 5.8).

A. Expression of Camui in HEK293T cells

1. Seed 150,000 cells in a round dish (35mm glass bottom dish with 20mm microwell #1

cover glass, D35-20-1-N) with 1mL of Dulbecco’s Modified Eagle’s Medium—high glucose
(Sigma Aldrich) + 10% of Fetal Bovine Serum (Sigma Aldrich).

2. Once the cells are 60–70% confluent (typically after 2–3 days), transfect with 600–700 ng

of Camui (mTurquoise2/mVenus) using Lipofectamine (Thermo Fischer) according to the
manufacturers protocol.

3. Subject Camui expressing cells to FLIM imaging as described in the procedure from
Measuring donor lifetime and FRET efficiency in the presence of an acceptor 48 h posttransfection.

B. Establishing timing of Ca2+ release in HEK293T cells by addition of ionomycin

Ca2+ entry into the cell leads to CaMKII activation. We use ionomycin to induce Ca2+ release

in HEK293T cells. In order to determine the kinetics of Ca2+ release after ionomycin

addition, we used Fluo-4 AM, a cell permeant Ca2+ indicator. Robust Ca2+ release occurred

roughly 40 s after addition of 2.5μM ionomycin.
C. Measuring CaMKII activity using Camui

As described above, Camui is a biosensor for CaMKII activation where there is a FRET

decrease coincident with CaMKII activation. Prior to Ca2+ release, CaMKII should be in the
OFF conformation and this is read out as a shorter lifetime from
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Camui. After ionomycin addition and subsequent Ca2+ release, CaMKII should be in the ON

conformation and this is read out as a longer lifetime from Camui. To provide a direct
comparison to the experiment described above, we cloned mTurquoise2 into Camui in place

of Cerulean. Furthermore, this version of Camui is better suited to FLIM analysis since
mTurquoise2 exhibits a mono-exponential decay in its lifetime while Cerulean does not.

Data acquisition and analysis were performed as described above. We acquired 60 million

photons before ionomycin addition, then ionomycin was added and after 40 s we began

another acquisition for 60 million photons. The only change compared to the proof of
concept 1 was in establishing the color display to a 600–4000 ps range.

5.7 Utilizing the Nikon A1-FLIM platform

Nikon and Becker & Hickl have collaborated to integrate the Becker & Hickl hardware into a

seamless module that is now part of Nikon’s software, NIS-Elements. The A1-FLIM module

combines advanced lifetime imaging technology with the software platform used to drive
conventional scanning confocal systems. The result is the ability to use typical confocal
system workflows to collect, visualize, and analyze lifetime data. The module allows for

multiplexed FLIM acquisition, providing Z-stacks, time-lapses, multi-points, or any

combination therein. All experiments are set up like normal confocal imaging on a Nikon

system using NIS-Elements. Thus, anyone familiar with a Nikon A1 confocal system can

begin to carry out lifetime experiments without specialized training. To begin an
experiment, one must first consider confocal imaging parameters including pinhole, image
speed and size and laser power. Once this is set, there are two settings necessary for

lifetime imaging; the capture mode and the time channels. Capture mode can be either a set
number of frames or can be dynamic based on the number of photons collected in a given

pixel. Generally, better contrast can be achieved with more data; however, the cost of doing
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so is time. Once these parameters are decided upon, one simply needs to press the “capture”
button in order to acquire lifetime images.
5.8 Conclusions

The hardware and protocols outlined here are meant to serve as an entry point for
researchers to begin thinking about how FLIM-FRET could benefit their research program

and, if it is deemed a worthwhile pursuit, how to assemble/purchase a system in their lab or

imaging facility. While we described Becker & Hickl TCSPC components connected to a
Nikon scanning confocal, other commercially available FLIM systems are available from

PicoQuant Photonics andas upgrade packages from major microscope companies such as

Leica, Olympus, and Zeiss, and we hope this chapter will inform comparison shopping
between the available options. It is also noteworthy that, in addition to FLIM-based

applications, these systems provide fluorescence correlation spectroscopy (FCS)
capabilities. In conclusion, FLIM-FRET offers significant improvements over conventional

intensity-based FRET approaches. Furthermore, creative FLIM-FRET applications that
would be impossible to accomplish with intensity-based FRET are and will continue to
arise. For example, the development of large Stoke’s shift (LSS) and “dark” fluorescent

proteins (Murakoshi et al., 2015; Shcherbakova et al., 2012) have facilitated the application
of dual FLIM-FRET applications in which multiple FRET-based sensors can be subjected to
FLIM simultaneously (Demeautis et al., 2017; Ringer et al., 2017) In this method, a single

wavelength (440 nm) can be used to excite two separate mono-exponential donors such as

the CFP variants mTurquoise2 or mTFP1 and LSSmOrange. The mTurquoise2 is paired with

a “dark” acceptor such as the GFP variant ShadowG, which has a 120-fold lower quantum
yield than EGFP and; therefore, emits very few photons when energy is transferred to it
from a donor, while the LSSmOrange is paired with mKate2 as an acceptor. Since there is no

overlap in the emission spectra of mTurquoise2/mTFP1 and LSSmOrange the lifetimes of
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each donor can be measured simultaneously with two TCSPC detectors following excitation
with the 445 nm pulsed laser. In the system described in this chapter this would simply

require changing the dichroic mirror and bandpass (BP) filters in the TCSPC module and a
dichroic mirror in the confocal scanning microscope. When acquiring dual FLIM data in a

modified setup, one window in the SPCM64 interface will display the mTurquoise2 signal

and the other window will display the LSSmOrange signal. Thus, analysis of each donor can
be conducted in SPCImage as described above to measure lifetimes and FRET efficiencies of
two FRET sensors in the same cell simultaneously. The fast pace at which TCSPC and

scanning confocal hardware is improving combined with the continued development of new

fluorescent proteins and dye-based technologies means that significant advancements in

FLIM-FRET in the vein of dual FLIM imaging will continue for years to come. We hope this

chapter will enable cell biologists to take advantage of these emerging technologies by
incorporating FLIM-FRET into their research programs.
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Figure 5.1 Schematic of how a decay curve is generated in the time-correlated
single photon counting (TCSPC) FLIM technique.
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Fig. 5.2 Schematic showing how a single exponential decay donor behaves in the
absence of FRET and when engaged in FRET with an acceptor.
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Fig. 5.3 Layout of the FLIM system outlined in this methods chapter. CW, continuous

wavelength; PMT, photomultiplier tube. Note 1: the CW lasers are contained in the box to
the right most edge of the photograph. Note 2: The “spectral detector” is part of the FLIM
system in the local user facility but is not used in the FLIM imaging protocol.
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Fig. 5.4. CyclinB1-Cdk1 FLIM-FRET reporter design. FRET increases when the sensor is

phosphorylated during mitosis due to a conformational change triggered by the Polo Box
Domain (PBD) of Polo-like kinase 1 (Plk1) binding to a phosphorylated recognition
sequence from human CyclinB1.
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Fig. 5.5. Lifetime analysis using SPCImage software (Becker & Hickl). This example

highlights analysis of the donor mTurquoise2 in the absence of acceptor using a mono-

exponential fit, which allowed us to measure the lifetime of the donor in our cell line.
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Fig. 5.6. Layout and principles of a phasor plot.
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Fig. 5.7. FLIM-FRET data analysis and visual display using the phasor plot. (A) Phasor

plot with both populations displayed in the FLIM image. (B) Single exponential population
(no FRET) in the phasor plot selected and displayed in the FLIM image. Note that the

interphase cell is all that is displayed in the FLIM image. (C) Double-exponential population
(FRET) in the phasor plot selected and displayed in the FLIM image. Note that the mitotic
cell is all that is displayed in the FLIM image.
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Fig. 5.8. Camui FLIM-FRET sensor for CaMKII activation. (A) The Camui sensor is

comprised of CaMKII, the domains are highlighted in the figure. In this version of Camui,

there is mVenus at the N-terminus and mTurquoise2 at the C-terminus of CaMKIIα. In the

presence of Ca2 +, Ca2 +-bound calmodulin (CaM) binds to CaMKII and turns activity ON. This
also results in a large conformational change where the kinase domain moves away from
the hub domain, causing a decrease in FRET, or higher lifetime measurement. (B)

Representative images of HEK293 cells expressing Camui are shown beneath the cartoon,

corresponding to low lifetime (left image) and high lifetime (right image). FRET efficiencies
and lifetimes are listed in the table given in this figure and numbers correspond to those
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ROIs highlighted in the images.

Table 1. Parts list and cost estimates for the compounds of TCSPC FLIM system.
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Table 2. Properties of fluorescent proteins donors that exhibit mono-exponential
decay.
(Ai et al., 2006; Betolngar et al., 2015; Demeautis et al., 2017; Goedhart et al., 2010, 2012;

Heikal et al., 2000; Kremers et al., 2006; Markwardt et al., 2011; Padilla-Parra et al., 2008;
Piatkevich & Verkhusha, 2011; Shaner et al., 2008, 2013; Shcherbakova et al., 2012)
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Table 3. Lifetime measurements of CyclinB1-Cdk1 reporters in proof of concept 1.
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Table 4. FRET efficiency measurements of soluble CyclinB1-Cdk1 reporters in proof
of concept 1.
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CHAPTER 6

FUTURE PERSPECTIVES ON CAMKII SUBUNIT EXCHANGE ROLE IN LONG-TERM
MEMORY FORMATION

6.1 Overview

Written by Torres-Ocampo Ana P.

This section will be addressing the current state of each project discussed in this

thesis work and its possible future directions for each. The work presented answered some
questions about CaMKII subunit exchange, but it also opened the door for new questions
about its mechanism, subunit exchange between CaMKII variants. It will also include the

topic of CaMKII holoenzyme stability and oligomerization state for each CaMKII holoenzyme
and hub domain.

6.2 CaMKII subunit exchange
So far, with data previously published (Bhattacharyya et al., 2016; M. Stratton et al., 2014)
and Chapter 2 from this thesis, it strongly suggested that all four CaMKII variants can go

through activation-triggered subunit exchange. For CaMKIIγ homo-oligomeric exchange, it
would be interesting to find another way to confirm subunit exchange since the single-

molecule TIRF approach is not feasible. By taking advantage of the already established
setup with the fluorescent dyes labeling for the CaMKII holoenzyme, one possible idea
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would be to show a mixed CaMKII, with red and green, i.e. an exchanged CaMKII, through

mass spectrometry or any other method that would allow us to quantify a holoenzyme with

both colors. It would also be interesting to look at hetero-oligomeric subunit exchange with

the other CaMKII variants, CaMKIIβ and CaMKIIδ. Once these experiments are performed, it
will be interesting to characterize their half-times and observe if the trend of slower the
hetero-oligomeric exchange is observed for all CaMKII variants.

For CaMKIIδ, the role of the AviTag still needs to be studied more thoroughly as the

FRET bulk assay with no AviTag for CaMKIIδ/CaMKIIδ did not show subunit exchange.

Nevertheless, when it is mixed with CaMKIIα with an AviTag, we observe subunit exchange.

Mass photometry could be used to study the effect of the AviTag in the holoenzyme stability

since it seems that it is facilitating exchange it by destabilizing the holoenzyme in some way.
The subsequent single-molecule TIRF experiments need to confirm that subunit exchange is
also observed in CaMKIIδ. Also, with both CaMKIIδ and CaMKIIγ, we need to test whether
they can also spread their phosphorylation state to previously unactivated CaMKIIs like

with CaMKIIα. Briefly, a CaMKII that is constitutively active by a T286D mutation, labeled
with one color, is mixed with an inactive CaMKII labeled with the other color. And then,

pThr286 is added labeled with a third color. Therefore, for the analysis, three colors are co-

localized instead of only two. After that is figured out, it would be fascinating to conduct
studies in neurons to study the effect of inhibiting subunit exchange during LTP and its
potential physiological consequences.

Lastly, by looking into the dynamics of CaMKII subunit exchange, my data suggest

that occupying the ATP binding pocket may affect holoenzyme stability and thus exchange.
The data shown was only using FRET bulk assay. In order to confirm these results, the

corresponding single-molecule TIRF experiments should be performed. Consequently, if the

single-molecule TIRF confirms that the ATP binding pocket is somehow regulating subunit
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exchange, then the current model of CaMKII subunit exchange will need to be modified to
include this new compelling evidence.
6.3 CaMKII holoenzyme stability

In Chapter 3, a comprehensive study of CaMKIIα holoenzyme stability was

presented. Here, we showed that the hub is more thermally stable compared to the kinase.

It was also shown that that the holoenzyme presents an intermediate thermal stability. Two
crystals structures of the kinase with and without regulatory segment were published.

Finally, we showed that the hub is very stable over a range of dilutions compared to the

holoenzyme. For that publication, we focused on only CaMKIIα, yet it would be intriguing to
characterize the other CaMKII variants and compare. The kinase and the hub have 90% and
75% identity, respectively. Thus, it be would be expected to show similar results as with
CaMKIIα. However, CaMKII never ceases to amaze us, and it would be enthralling to
compare the whole panel of stability of holoenzyme stability: DSC, MP, and crystal

structures of the kinases. The linker length for CaMKIIα did show to be essential for neither
thermal stability nor dissociation patterns, but it would be curious to see if this holds true
for the other CaMKII variants.

6.4 CaMKII oligomerization state
Chapter 4 dives into how the oligomerization state of CaMKII is related to thermal stability
and possibly regulating calcium sensitivity. All of these experiments were done using
unactivated CaMKII. Hence, comparing unactivated CaMKII with active CaMKII and

observing how their oligomerization states vary or not would be delightful! It would be

expected that indeed there would be a difference because active CaMKII is going through

subunit exchange once it becomes active, and doing this experiment would provide a clue as
to what happens to CaMKII oligomerization state. The current model states that it happens
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via a dimeric subunit; however, there is no direct evidence of this. As mentioned before, it

would also be interesting to see if the linker affects how this happens. For CaMKIIα, it is not
necessary for subunit exchange.
6.5 CaMKII FRET biosensor

Chapter 5 allowed me to work with Camui, a FRET biosensor for CaMKII activity and

FLIM-FRET. Currently, there is another FRET biosensor, FRESCA, which measures

endogenous CaMKII activity. FRESCA was tested in eggs in collaboration with Rafael

Fissore’s laboratory. It would be fascinating to put this sensor into neurons and be able to

measure CaMKII endogenous activity. Camui has been previously used in neurons, but it has

its limitations. Of course, it would be excellent if we can get the FLIM-FRET set up to work in
conjunction with FRESCA in neurons!
6.6 Conclusions

CaMKII is an enzyme that keeps delighting me and surprising me. It helped me

become a scientist, and I am looking forward to keeping up with its upcoming discoveries

done in the Stratton lab. There is still a lot to know about this engaging protein. Doing all of
these biochemical and biophysical characterizations of CaMKII always opens the door for

me to think about if everything we see in vitro can also be observed in vivo. Specifically, with

subunit exchange, I am looking forward to the day I get the email about how it does have a
role during LTP (hopefully!). Most of the focus should be on cells using fluorescence
microscopy, CRISPR, and FRET biosensors. All the best CaMKII, it was fun.
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APPENDIX

A1. Mass spectrometry data showing partial biotinylation of purified CaMKII.

A2. Western blot for CaMKII using pan CaMKII and pThr286 antibody. We used

panCaMKII to detect CaMKII monomer as a positive control and ULP1 as a negative control.
And for pThr286, we use ULP1 as a negative control, activated CaMKII as a positive control,
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dephosphorylated CaMKII and CaMKII from the purification. No background
phosphorylation was detected.
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